[go: up one dir, main page]

TW200812571A - Sugar-coated preparation and process for producing the same - Google Patents

Sugar-coated preparation and process for producing the same Download PDF

Info

Publication number
TW200812571A
TW200812571A TW096126949A TW96126949A TW200812571A TW 200812571 A TW200812571 A TW 200812571A TW 096126949 A TW096126949 A TW 096126949A TW 96126949 A TW96126949 A TW 96126949A TW 200812571 A TW200812571 A TW 200812571A
Authority
TW
Taiwan
Prior art keywords
sugar
coating
coated
coating liquid
preparation
Prior art date
Application number
TW096126949A
Other languages
Chinese (zh)
Inventor
Tatsuharu Shimokawa
Hiroyuki Kawashima
Original Assignee
Kowa Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kowa Co filed Critical Kowa Co
Publication of TW200812571A publication Critical patent/TW200812571A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005Wall or coating material
    • A61K9/5015Organic compounds, e.g. fats, sugars
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/28Dragees; Coated pills or tablets, e.g. with film or compression coating
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005Wall or coating material
    • A61K9/5021Organic macromolecular compounds
    • A61K9/5026Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Inorganic Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Obesity (AREA)
  • Cardiology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

A technique for producing a sugar-coated preparation which has sufficient hardness and is excellent in low moisture absorption, a deodorizing property and disintegratability easily in a short time is provided. Specifically, a sugar-coating liquid which can be preferably used in the production of a sugar-coated preparation using a continuous coating method in which a step of spraying the sugar-coating liquid and a drying step are simultaneously conducted, a sugar-coated preparation with a sugar-coating layer formed with the sugar-coating liquid, and a process for producing the same are provided. The sugar-coated preparation is produced using the sugar-coating liquid containing an ethyl acrylate/methyl methacrylate copolymer and a solvent wherein the concentration of the ethyl acrylate/methyl methacrylate copolymer is 0.01 to 10% by weight based on the total solid component.

Description

200812571 九、發明說明 【發明所屬之技術領域】 本發明係關於糖衣製劑及其製造方法。 【先前技術】 糖衣製劑係因爲該糖衣層具有防止氧、水、臭味成份 透過之機能,所以低透氧性、低吸濕性、防臭性優異,適 合安定化素錠所配合成份之劑形。 例如大蒜加工物係具有除了消除疲勞或滋養強壯效果 之外,以及增強胃收縮力作用、促進新陳代謝作用、促進 血流作用、保護肝作用等,廣泛地作爲醫藥品使用,但因 爲熱或水份的影響而發生臭味,所以大多已糖衣製劑化。 另外,氯化甲硫胺基酸(Methylmethioninesulfonium chloride,以下亦稱爲「MMSC」。)係具有改善胃潰瘍、 十二指腸潰瘍、胃炎等之自覺症狀及他覺所見、改善慢性 肝疾病中之肝機能等之緩和各種症狀等之作用,廣泛地作 爲醫藥品使用。然而,因爲MMSC具有吸收空氣中的水份 而分解之性質,所以含MMSC之製劑係具有發生臭味、變 色、有效成份含量降低等之品質降低之問題。因此’以防 止吸濕爲目的,大多的MMSC製劑已糖衣製劑化(專利文 獻 1 、 2)。 另外,丙戊酸鈉係廣泛地作爲小發作、部分性發作、 精神運動性發作以及混合發作等之各種癲癇、糜瘤所伴隨 之性格行動障礙(心情不佳、易怒性等)、及焦慮症及躁 -5- 200812571 鬱症之焦慮狀態治療用之醫藥品使用。然而,丙戊酸鈉具 有吸濕性及潮解性,以防止開封後之品質降低爲目的,已 糖衣製劑化(專利文獻3、4 )。 糖衣製劑係一般由反覆數次之[1]糖衣液之噴霧、[2] 蒸煮、[3]乾燥所製造(例如專利文獻5 )。其中[2]蒸煮 係將糖衣製劑之側面完全埋入,用以使噴霧之糖衣液均勻 地展開於素錠上之步驟,通常使用具有高黏度之糖液時, 爲不可欠缺之步驟。另一方面,含如此步驟之糖衣製劑之 製造方法係有需要非常長的作業時,對於素錠需要多量的 糖衣液等之不利面。 作爲克服上述不利面之製造方法,檢討藉由如製造薄 膜被覆錠,噴霧被覆液下進行乾燥,形成被覆層之方法( 以下亦稱爲連續被覆法。)以形成糖衣層之方法。於連續 被覆法’因爲必須將噴霧糖衣液迅速地、均句地展開於素 錠等之芯材上,所以要求稀釋糖衣液,降低黏度。因此, 例如使用懸浮糖及滑石之糖衣液,開發形成薄層糖衣層之 技術等(專利文獻6 )。然而,如此之薄層糖衣層與傳統 品相比較,有強度差之問題。另外,作爲改善薄層糖衣層 強度之方法,亦開發例如於薄膜被覆錠與糖衣層之間設有 中間層之技術等(專利文獻7 )。然而因爲如此方法包含 調製、噴霧具有與糖衣層相異的組成之被覆液,所以難稱 得上是非常簡便者。另外,取代通常作爲結合劑所使用之 阿拉伯膠或明膠,使用羥丙基甲基纖維素或羥丙基纖維素 ,亦開潑降低糖衣液黏度之技術(專利文獻8 )。然而, -6- 200812571 藉由此方法所得之糖衣層係有緻密性不足’糖衣製劑特徵 之低氧透過性、低吸濕性、防臭性差之問題。 如此地對於糖衣製劑之製造方法或糖衣液’雖從改善 作業性及製劑特性之兩方面進行各種檢討’但仍未開發兩 者皆改善之技術。 專利文獻1 :特開2003 -63 953號公報 專利文獻2 :特開2003-95928號公報 專利文獻3 :特開2006-25696 1號公報 專利文獻4 :特開平04-23 59 1 4號公報 專利文獻5 :特開平06-2925 1 1號公報 專利文獻6 :特開昭56- 875 1 8號公報 專利文獻7 :特開2004- 1 55656號公報 專利文獻8 ··特開昭49- 1 3 3 5 1 5號公報 【發明內容】 [發明之揭示] 本發明係以提供可短時間且簡易地製造具有充份的硬 度,而且低吸濕性、防臭性、崩壞性優異之糖衣製劑之技 術。具體上,提供可適合使用於使用同時進行糖衣液之噴 霧步驟、及乾燥步驟之連續被覆法以製造糖衣製劑之糖衣 液、具有由此糖衣液所形成之糖衣層之糖衣製劑及其製造 方法爲課題。 本發明者等對於適用於連續被覆法之糖衣液組成,進 行各種檢討。接著,發現於含糖溶劑中,以特定比率配合 200812571 丙烯酸乙酯·甲基丙烯酸甲酯共聚物之糖衣液,具有適合 連續被覆法之物性,藉由使用具有如此組成之糖衣液之連 續被覆法所形成之糖衣層之糖衣製劑係具備低吸濕性、防 臭性、及良好崩壞性,而完成本發明。 亦即,本發明係提供含丙烯酸乙酯·甲基丙烯酸甲酯 共聚物及溶劑之糖衣液,丙烯酸乙酯·甲基丙烯酸甲酯共 聚物之濃度係相對於總固形物爲0.01〜10重量%之糖衣液 、使用該糖衣液,製造糖衣製劑之方法、及由此製造方法 所得之糖衣製劑者。 [用以實施發明之最佳型態] 本發明之糖衣液係含糖、丙烯酸乙酯·甲基丙烯酸甲 酯共聚物、及溶劑。 本發明使用的糖係只要通常形成糖衣製劑之糖衣層所 使用的糖即可使用,並無特別的限制,可舉例如白砂糖、 精製白糖、白糖、葡萄糖、海藻糖等。其中,白砂糖、精 製白糖、白糖可適合使用。 本發明之糖衣液中,糖的配合量雖無特別的限制,但 通常爲10〜85重量%,以10〜70重量%爲宜,以15〜60 重量%尤佳。 本發明使用之丙烯酸乙酯·甲基丙烯酸甲酯共聚物係 指丙烯酸乙酯與甲基丙烯酸甲酯共聚合之聚合物。共聚物 之數平均分子量係只要於賦予糖衣製劑適當的硬度及崩壞 性之範圍即可,但通常爲10,000〜1,500,000,以400,000 200812571 〜1,200,000 爲宜,以 500,000 〜151〇〇,〇〇〇 尤佳。另外, 構成共聚物之丙烯酸乙酯與甲基丙烯酸甲酯之莫耳比,通 常爲10: 1〜1: 10,以4: 1〜1:4爲宜,進而,以3: 1 〜1 : 3尤佳。另外,共聚物之玻璃轉移溫度範圍通常爲_ 40°C 〜3 0°C,以- 3 0°C 〜20°C 爲宜,以- 20°C 〜10°C 尤佳。 丙烯酸乙酯·甲基丙烯酸甲酯共聚物係可依據常法, 使丙烯酸乙酯與甲基丙烯酸甲酯共聚合而得。另外,丙烯 φ 酸乙酯·甲基丙烯酸甲酯共聚物,亦可使用市售品。作爲 市售品,可舉例如使用界面活性,分散丙烯酸乙酯·甲基 丙烯酸甲酯共聚物於水之乳濁液之EudragitNE30D (樋□ 商會)、ColicoatEMM30D ( BASF 日本)等。 本發明之糖衣液中,丙烯酸乙酯·甲基丙烯酸甲酯共 聚物之配合量係相對於糖衣液中所含總固形物爲0.0 1〜1 〇 重量%。其中,以〇·1〜8重量%爲宜。配合量若超過1〇重 量%時,糖衣液中懸浮之固形物發生凝聚,並不適宜。 φ 本發明之糖衣液中,丙烯酸乙酯·甲基丙烯酸甲酯共 聚物與糖之質量比,通常爲1 : 1〜1 : 1 0,0 0 0,以1 : 3〜 1 : 1,000爲宜,以1 : 5〜1 : 5 00尤佳。 作爲本發明之糖衣液之溶劑,只要通常糖衣液所使用 者即可,並無特別的限制。可舉例如水、乙醇、異丙醇等 之低級醇、丙酮或此等之混合物。此等溶劑中,通常精製 水適合使用。 糖衣液中溶劑的配合量雖無特別的限制,但通常爲1 5 〜9 0重量%,以1 5〜8 5重量%爲宜,以2 0〜8 0重量%尤 -9 - 200812571 佳。溶劑之配合量若超過90重量%時,用以形成糖衣層之 作業時間變長,將難以形成緻密的糖衣層,對芯材所含藥 物之安定性造成影響。另外,未滿1 5重量%時,糖衣液的 黏性變高,而有錠劑附著於錠劑被覆裝置平盤等之作業性 問題,另外,由連續被覆法製造糖衣製劑時,不能於錠劑 表面均勻地展開糖衣液,不能形成均勻厚度之糖衣層。另 外,糖衣液之黏度係只要可由使用於製造糖衣製劑之裝置 噴霧之範圍即可,通常亦可調節溶劑之配合量以成爲3〜 l,000cp,以5〜700cp爲宜,以10〜400cp尤佳。 本發明之糖衣液係除了上述各成份以外,可因應要, 配合作爲醫藥之添加物所容許,且可經口投予之各種任意 成份。作爲如此之添加劑,可舉例如被覆劑、著色劑及光 澤化劑等。 作爲被覆劑,有羥丙基纖維素、羥丙基甲基纖維素 2910、羥丙基甲基纖維素2208、甲基纖維素、聚乙烯醇、 聚乙烯基吡咯烷酮、結晶纖維素、阿拉伯膠粉末、精製蟲 膠、普路蘭、沈澱碳酸鈣、滑石、磷酸氫鈣、輕質矽酸酐 、含水二氧化矽、氧化鈦、磷酸二氫鈉、硬化油、單硬脂 酸甘油酯及單硬脂酸聚乙二醇酯等,該配合量係相對於糖 衣液,以〇〜8 0重量%爲宜。 作爲著色劑,例如有各種食用色素、焦油色素及三氧 化二鐵等,該配合量係相對於糖衣製劑,以〇· 1重量%以 下爲宜。 作爲光澤劑,例如有巴西棕櫚鱲或蜂鱲等,該配合量 -10- 200812571 係相對於糖衣製劑,以〇· 1重量%以下爲宜。 本發明之糖衣液之黏度通常爲3〜l,〇〇〇cp,以5〜 700cp爲宜,以10〜400cP尤佳。若使用如此黏度範圍之 糖衣液,由連續被覆法製造糖衣製劑時,將容易形成均勻 的糖衣層。 本發明之糖衣液係可由懸浮糖、丙烯酸乙酯·甲基丙 烯酸甲酯共聚物及因應需要之上述任意成份於溶劑而製造 。此時,爲充份地分散丙烯酸乙酯·甲基丙烯酸甲酯共聚 物於溶劑中,以加入界面活性劑爲宜。 本發明之糖衣製劑係於含藥物之芯材周圍,具有至少 一層使用本發明之糖衣液形成之糖衣層。 本發明之糖衣製劑所含之作爲含有藥物之芯材,可舉 例如素錠或芯顆粒。亦即,本發明之糖衣製劑係可爲例如 糖衣錠或糖衣顆粒之劑形。 本發明中,作爲芯材所含有之藥物係已經確認藉由經 口投予之安全性之藥物,只要適合糖衣製劑者即可,並無 特別的限制,可舉例如具有不愉快臭味之藥物、對水不安 定之藥物、發生晶鬚之藥物等爲宜。作爲具有不愉快臭味 之藥物,可舉例如生藥(羰基脒(0xoamidine )粉末、啤 酒花、薏苡仁、當藥、人蔘、黄耆、茴香、丁香、生薑及 茛菪萃取物等)、大蒜加工物、氯化甲硫胺基酸、L_半胱 胺酸及維生素B1類等,作爲對水不安定之藥物,可舉例 如各種維生素(維生素A類、維生素B!類、維生素β2類 、維生素B6類、維生素B12類、維生素C類、維生素〇 -11 - 200812571 類、維生素E類、生物素、泛酸鈣、煙醯胺、維生素P及 其衍生物等)、氯化甲硫胺基酸、胺基酸類(天冬胺酸及 L_半胱胺酸等)、腺核苷三磷酸·2鈉鹽、酵素(澱粉消化 酵素、蛋白質消化酵素、脂肪消化酵素及纖維素消化酵素 等)、丙戊酸鈉、布洛芬(Ibuprofen )、呱芬那辛( Guaifenesin )及 丁溴東莨菩鹼(Scopolamine Butylbromide)等,作爲發生晶鬚之藥物,可舉例如布洛 芬 (Ibuprofen )、無水咖啡因、乙氧基苯胺 ( Ethenzamide )、異丙安替比林(Isopropylantipyrine )及 L-薄荷醇等。此等藥物之配合量雖可因應藥物用途而適當 調整,但相對於芯材,以0.1〜99重量%爲宜,以 1〜85 重量%尤佳。 本發明中作爲芯材所含有之藥物,可舉例如下述之藥 物爲宜。 [大蒜加工物] 大蒜加工物係將百合科蔥屬大蒜(Allium sativum 1. )之鱗莖加工處理所得者。加工處理的方法並無特別的限 制,可使用例如將生大蒜乾燥後粉末化者、將生大蒜以水 蒸氣蒸餾、油、水、熱水或水溶性有機溶劑等萃取者、將 生大蒜由加熱等處理者。作爲萃取用油,可舉例如菜籽油 、橄欖油、大豆油等之食用植物油,作爲水溶性有機溶劑 ,可舉例如乙醇、異丙醇等之低級醇;丙二醇、二乙二醇 等之甘醇等。作爲大蒜加工物係以乾燥後粉末化者、由低 -12-200812571 IX. Description of the Invention [Technical Field of the Invention] The present invention relates to a sugar-coated preparation and a method of producing the same. [Prior Art] Since the sugar-coated layer has a function of preventing oxygen, water, and odor components from passing through, the sugar-coated layer is excellent in low oxygen permeability, low moisture absorption, and odor-reducing property, and is suitable for the formulation of the ingredients of the stable chemical ingot. . For example, the garlic processing system has the effects of eliminating fatigue or nourishing and strengthening, enhancing the gastric contraction force, promoting metabolism, promoting blood flow, and protecting the liver, and is widely used as a medicine, but because of heat or moisture. The odor is caused by the influence, so most of the sugar coatings have been formulated. In addition, Methylmethionine sulfonium chloride (hereinafter also referred to as "MMSC") has the symptoms of improving gastric ulcer, duodenal ulcer, gastritis, and the like, and improving liver function in chronic liver diseases. It is widely used as a pharmaceutical product to alleviate the effects of various symptoms and the like. However, since MMSC has a property of decomposing by absorbing moisture in the air, the preparation containing MMSC has a problem of deterioration in quality such as odor, discoloration, and reduction in the content of active ingredients. Therefore, most of the MMSC preparations have been sugar-coated for the purpose of preventing moisture absorption (Patent Documents 1 and 2). In addition, sodium valproate is widely used as a small seizure, partial seizure, psychomotor seizure, and mixed seizures, such as personality disorders (hypermune, irritability, etc.) and anxiety Symptoms and 躁-5- 200812571 The use of drugs for the treatment of anxiety in depression. However, sodium valproate has a hygroscopic property and deliquescent property, and it has been prepared for the purpose of preventing the quality of the product after opening. (Patent Documents 3 and 4). The sugar-coating preparation is generally produced by spraying [1] a sugar coating liquid, [2] cooking, and [3] drying several times (for example, Patent Document 5). Among them, [2] cooking is a step in which the side of the sugar-coated preparation is completely embedded, so that the sprayed coating liquid is uniformly spread on the ingot, and it is an indispensable step when a sugar liquid having a high viscosity is usually used. On the other hand, the manufacturing method of the sugar-coated preparation containing such a step is disadvantageous in that a large amount of the sugar-coating liquid or the like is required for the prime ingot when a very long work is required. As a manufacturing method for overcoming the above-mentioned disadvantageous surface, a method of forming a coating layer by a method of producing a coating layer by drying a spray coating liquid to form a coating layer by a method of forming a coating layer (hereinafter also referred to as a continuous coating method) is reviewed. In the continuous coating method, since the spray coating liquid must be rapidly and uniformly spread on the core material such as a tablet, it is required to dilute the sugar coating liquid to lower the viscosity. Therefore, for example, a technique of forming a thin layer of sugar-coated layer using a sugar-coating liquid of suspended sugar and talc is developed (Patent Document 6). However, such a thin layer of sugar-coated layer has a problem of poor strength compared to conventional ones. In addition, as a method of improving the strength of the thin layer of the sugar-coated layer, for example, a technique of providing an intermediate layer between the film-coated ingot and the sugar-coated layer has been developed (Patent Document 7). However, since such a method involves modulating and spraying a coating liquid having a composition different from that of the sugar coating layer, it is difficult to say that it is very simple. Further, in place of the gum arabic or gelatin which is usually used as a binder, hydroxypropylmethylcellulose or hydroxypropylcellulose is used, and the viscosity of the coating liquid is also lowered (Patent Document 8). However, -6-200812571 The sugar-coated layer obtained by this method has a problem that the density of the sugar-coated preparation is low in oxygen permeability, low in moisture absorption, and poor in odor resistance. As described above, the method for producing a sugar-coated preparation or the sugar-coating liquid has been subjected to various reviews in terms of improvement in workability and formulation characteristics, but no technology has been developed. Patent Document 1: Japanese Laid-Open Patent Publication No. 2003-95928, Patent Document 2: JP-A-2003-95928 Patent Document 3: JP-A-2006-25696 No. 1 Patent Publication No. 4: JP-A No. 04-23 No. Japanese Unexamined Patent Publication No. JP-A No. Hei. No. Hei. No. Hei. No. Hei. No. Hei. SUMMARY OF THE INVENTION [Disclosure of the Invention] The present invention provides a sugar coating preparation which is capable of producing a sufficient hardness in a short period of time and which is excellent in low hygroscopicity, odor resistance, and collapse property. technology. Specifically, a sugar coating preparation suitable for use in a continuous coating method in which a sugar coating liquid is sprayed and a drying step is used to produce a sugar coating preparation, a sugar coating preparation having the sugar coating layer formed from the sugar coating liquid, and a method for producing the same are provided. Question. The inventors of the present invention conducted various reviews on the composition of the coating liquid suitable for the continuous coating method. Next, it was found that a sugar coating liquid of 200812571 ethyl acrylate/methyl methacrylate copolymer was blended in a sugar-containing solvent at a specific ratio, and the physical properties suitable for the continuous coating method were obtained by using the continuous coating method of the sugar coating liquid having such a composition. The sugar-coated preparation of the formed sugar-coated layer has low hygroscopicity, deodorant property, and good collapse property, and the present invention has been completed. That is, the present invention provides a sugar coating liquid containing an ethyl acrylate-methyl methacrylate copolymer and a solvent, and the concentration of the ethyl acrylate/methyl methacrylate copolymer is 0.01 to 10% by weight based on the total solid content. A sugar coating liquid, a method of producing a sugar coating preparation using the sugar coating liquid, and a sugar coating preparation obtained by the production method. [Best Mode for Carrying Out the Invention] The sugar coating liquid of the present invention is a sugar-containing, ethyl acrylate-methyl methacrylate copolymer, and a solvent. The sugar to be used in the present invention is not particularly limited as long as it is usually used to form a sugar-coated layer of a sugar-coated preparation, and examples thereof include white sugar, refined white sugar, white sugar, glucose, and trehalose. Among them, white sugar, fine white sugar and white sugar can be used. In the sugar coating liquid of the present invention, the amount of the sugar is not particularly limited, but is usually 10 to 85% by weight, preferably 10 to 70% by weight, particularly preferably 15 to 60% by weight. The ethyl acrylate/methyl methacrylate copolymer used in the present invention means a polymer obtained by copolymerizing ethyl acrylate and methyl methacrylate. The number average molecular weight of the copolymer may be within a range that imparts appropriate hardness and collapse to the sugar coating preparation, but is usually 10,000 to 1,500,000, preferably 400,000 200812571 to 1,200,000, and 500,000 to 151 Å. Yu Youjia. Further, the molar ratio of ethyl acrylate and methyl methacrylate constituting the copolymer is usually 10:1 to 1:10, preferably 4:1 to 1:4, and further, 3:1 to 1: 3 is especially good. Further, the glass transition temperature of the copolymer is usually in the range of _ 40 ° C to 30 ° C, preferably - 30 ° C to 20 ° C, preferably - 20 ° C to 10 ° C. The ethyl acrylate-methyl methacrylate copolymer can be obtained by copolymerizing ethyl acrylate and methyl methacrylate according to a usual method. Further, a commercially available product can also be used as the propylene φ acid ethyl ester/methyl methacrylate copolymer. As a commercially available product, for example, Eudragit NE30D (樋□ Chamber of Commerce), Colicoat EMM30D (BASF Japan), which disperses an ethyl acrylate/methyl methacrylate copolymer in water emulsion, can be used. In the sugar coating liquid of the present invention, the amount of the ethyl acrylate/methyl methacrylate copolymer is 0.01 to 1% by weight based on the total solid content contained in the sugar coating liquid. Among them, 〇·1 to 8 wt% is preferred. When the compounding amount exceeds 1% by weight, the solid matter suspended in the sugar coating liquid is agglomerated, which is not suitable. φ In the sugar coating liquid of the present invention, the mass ratio of ethyl acrylate·methyl methacrylate copolymer to sugar is usually 1: 1 to 1 : 1 0, 0 0 0 to 1: 3 to 1 : 1,000 It is advisable to take 1: 5~1: 5 00 especially good. The solvent of the sugar coating liquid of the present invention is not particularly limited as long as it is usually used as a sugar coating liquid. For example, a lower alcohol such as water, ethanol or isopropyl alcohol, acetone or a mixture of these may be mentioned. Of these solvents, usually purified water is suitable for use. The amount of the solvent in the sugar-coating liquid is not particularly limited, but is usually from 1 5 to 90% by weight, preferably from 1 5 to 85% by weight, particularly preferably from 20 to 80% by weight, particularly preferably from -9 to 200812571. When the amount of the solvent is more than 90% by weight, the working time for forming the sugar-coated layer becomes long, and it is difficult to form a dense sugar-coated layer, which affects the stability of the drug contained in the core material. In addition, when the amount is less than 15% by weight, the viscosity of the coating liquid becomes high, and the tablet adheres to the flatness of the tablet coating device, and the like, and when the sugar coating preparation is produced by the continuous coating method, the ingot cannot be used. The surface of the agent is evenly spread out of the sugar coating liquid, and a sugar coating layer of uniform thickness cannot be formed. In addition, the viscosity of the sugar-coating liquid may be as long as it can be sprayed by the device used for the manufacture of the sugar-coated preparation, and the amount of the solvent may be adjusted to be 3 to 1,000 cp, preferably 5 to 700 cp, and 10 to 400 cp. good. In addition to the above-mentioned respective components, the sugar-coating liquid of the present invention may be blended with any of various components which can be orally administered as the medical additive is allowed. As such an additive, for example, a coating agent, a coloring agent, a photo-forming agent, and the like can be given. As the coating agent, there are hydroxypropylcellulose, hydroxypropylmethylcellulose 2910, hydroxypropylmethylcellulose 2208, methylcellulose, polyvinyl alcohol, polyvinylpyrrolidone, crystalline cellulose, gum arabic powder. , refined shellac, pululolan, precipitated calcium carbonate, talc, calcium hydrogen phosphate, light phthalic anhydride, aqueous cerium oxide, titanium oxide, sodium dihydrogen phosphate, hardened oil, glyceryl monostearate and mono-hard fat The acid polyethylene glycol ester or the like is preferably used in an amount of 〇80% by weight based on the sugar coating liquid. As the coloring agent, for example, various food coloring matters, tar coloring matter, and ferric oxide are used, and the compounding amount is preferably 〇·1% by weight or less based on the sugar coating preparation. The glossing agent is, for example, a palmetto or a bee sting, and the compounding amount is -10-200812571, preferably 3% by weight or less based on the sugar-coated preparation. The viscosity of the sugar coating liquid of the present invention is usually 3 to 1, 〇〇〇 cp, preferably 5 to 700 cp, and particularly preferably 10 to 400 cP. When a sugar coating liquid having such a viscosity range is used, when a sugar coating preparation is produced by a continuous coating method, a uniform sugar coating layer is easily formed. The sugar coating liquid of the present invention can be produced from a suspension sugar, an ethyl acrylate-methyl methacrylate copolymer, and any of the above-mentioned optional components in a solvent. In this case, it is preferred to sufficiently disperse the ethyl acrylate-methyl methacrylate copolymer in a solvent to add a surfactant. The sugar-coating preparation of the present invention is applied around a drug-containing core material and has at least one layer of a sugar coating layer formed using the sugar coating liquid of the present invention. The sugar-coated preparation of the present invention contains, as a core material containing a drug, a plain ingot or a core particle. That is, the sugar-coating preparation of the present invention may be in the form of, for example, a sugar-coated tablet or a sugar-coated granule. In the present invention, the drug to be safely administered by the oral administration is not particularly limited as long as it is suitable for the sugar-coated preparation, and may be, for example, a drug having an unpleasant odor. It is advisable to use drugs that are not stable in water, drugs that produce whiskers, and the like. Examples of the drug having an unpleasant odor include a crude drug (oxoquinone powder, hop, coix seed, medicine, mantis, scutellaria, fennel, clove, ginger, and medlar extract), and garlic processing. As a drug that is unstable to water, for example, vitamin A, vitamin B!, vitamin beta 2, vitamins, etc. B6, vitamin B12, vitamin C, vitamin 〇-11 - 200812571, vitamin E, biotin, calcium pantothenate, nicotinamide, vitamin P and its derivatives, etc.), methionine, Amino acids (aspartic acid and L-cysteine, etc.), adenosine triphosphate 2 sodium salt, enzymes (starch digestive enzymes, protein digestive enzymes, fat digestive enzymes and cellulose digestive enzymes, etc.), C Sodium valerate, Ibuprofen, Guaifenesin, and Scopolamine Butylbromide, etc., as a drug for generating whiskers, for example, Ibuprofen, anhydrous coffee Cause, B Aniline (Ethenzamide), propyphenazone (Isopropylantipyrine) L- menthol and the like. The compounding amount of these drugs may be appropriately adjusted depending on the use of the drug, but it is preferably 0.1 to 99% by weight, more preferably 1 to 85% by weight, based on the core material. In the present invention, as the drug contained in the core material, for example, the following drugs are preferable. [Garlic processed product] The garlic processed product is obtained by processing the bulb of Allium sativum 1. The method of processing is not particularly limited, and for example, the raw garlic is dried and powdered, and the raw garlic is extracted by steam distillation, oil, water, hot water or a water-soluble organic solvent, and the raw garlic is heated. Wait for the processor. Examples of the oil for extraction include edible vegetable oils such as rapeseed oil, olive oil, and soybean oil. Examples of the water-soluble organic solvent include lower alcohols such as ethanol and isopropyl alcohol; and glycols such as propylene glycol and diethylene glycol. Alcohol, etc. As a garlic processing system, after drying, powdering, by low -12-

200812571 級醇萃取者、加熱之加工處理者尤佳。 亦可爲市售品。例如加工大蒜、大蒜萃 、乾燥大_寺爲宜’以加工大赫尤佳。 以低級醇萃取加熱處理大蒜,乾燥所得 ,例如市售之Oxoamidine (註冊商標) 股)製)及Oxoredine (註冊商標)( )製)。大蒜萃取物係例如市售之大蒜 工業(股))、大蒜流萃取物(日本較 。乾燥大蒜係例如市售之大蒜粉末、炎 硏化學工業(股)製)。此等市售之 Oxoamidine (註冊商標)(理硏化學 Oxoredine (註冊商標)(理硏化學工 穿示竿取物(A1 p s樂品工業(股))、> 粉末藥品(股))爲宜。大蒜加工物5 衣製劑之用途而適當調整,但以相對於 %爲宜,以5〜1 5重量%尤佳。 [氯化甲硫胺基酸] 氯化甲硫胺基酸(MMSC )係可依 而得。另外,作爲市售品,例如市售毒 澤濱理藥品製、Alps藥品工業製)等< 相對於芯材,以1〜80重量%爲宜,以 另外,配合MMSC之芯材中,使 另外,大蒜加工物 :取液、大蒜萃取物 在此,加工大蒜係 。萃取液之大蒜粉末 (理硏化學工業( 理硏化學工業(股 萃取物(A1 p s樂品 〖末藥品(股))等 琴大蒜粉末EX (理 大蒜加工物中係以 工業(股)製)、 業(股)製)、大 C蒜流萃取物(曰本 :配合量雖可因應糖 芯材之2〜3 0重量 據已知的製造方法 化甲硫胺基酸(米 MMSC之配合量係 1 0〜4 0重量%尤佳 含有中和胃酸成份 -13- 200812571 或抑制胃酸分泌成份(制酸成份)、提高胃機能之成份( 健胃成份)、輔助消化成份(消化酵素)、修復胃黏膜之 成份(黏膜修復成份)等尤佳。 作爲制酸成份,可舉例如合成Hydrotalcite、碳酸氫 鈉、矽酸鋁酸鎂、氫氧化鋁·碳酸氫鈉共沈物、莨菪萃取 物、氫氧化鋁、碳酸氫鈉、碳酸鎂、沈澱碳酸鈣、沈澱碳 酸鎂、二羥基鋁胺基醋酸鹽、氫氧化鎂、氧化鎂、乾燥氫 氧化鋁凝膠、矽酸鋁酸鎂鉍、矽酸鎂、合成矽酸鋁、鹽酸 雷尼替丁 (Ranitidine Hydrochloride )、西咪替丁 ( Cimetidine ) 、Famotidine、尼扎替丁(Nizatidine)、拉 咲替丁 ( Lafutidine ) 、Omeprazole、Lansoprazole、200812571 alcohol extractor, heating processing processor is especially good. It can also be a commercial item. For example, processing garlic, garlic extract, and drying the big _ temple is suitable for processing Dahe Youjia. The garlic is heat-treated with a lower alcohol, and dried, for example, as commercially available from Oxoamidine (registered trademark) and Oxoredine (registered trademark) ( ). The garlic extract is, for example, a commercially available garlic industry (stock), and a garlic extract (Japanese, dried garlic, for example, commercially available garlic powder, manufactured by Yankee Chemical Industry Co., Ltd.). Such commercially available Oxoamidine (registered trademark) (Technology Oxoredine (registered trademark) (the skilled chemical worker wears the extract (A1 ps music industry (share)), > powder medicine (share)) Garlic processed material 5 is suitably adjusted for use, but it is preferably 5 to 15% by weight, preferably relative to %. [Methylthiomethic acid] methionine acid (MMSC) In addition, as a commercial product, for example, a commercially available Toshihide Pharmaceutical Co., Ltd., manufactured by Alps Pharmaceutical Co., Ltd., etc., it is preferably 1 to 80% by weight based on the core material, and further, MMSC is blended. In the core material, in addition, the garlic processed product: the liquid extract and the garlic extract are processed here, and the garlic system is processed. Garlic powder for extracts (Lily Chemical Industry (Liquor Chemicals (A1 ps music, 〖End drug (shares)) and other Qin garlic powder EX (Like garlic processed by Industrial Co., Ltd.) , industry (stock) system, large C garlic flow extract (sakamoto: the amount can be adjusted according to the sugar core material 2 ~ 30 weight according to the known manufacturing method of methyl thiomethic acid (M MMSC compounding amount Department 1 0~40% by weight, especially containing neutralizing gastric acid component-13-200812571 or inhibiting gastric acid secretion (acidic component), improving gastric function (stomach component), auxiliary digestion (digestive enzyme), repair The composition of the gastric mucosa (mucosal repair component) is particularly preferable. As the acid component, for example, synthetic Hydrotalcite, sodium hydrogencarbonate, magnesium niobate aluminate, aluminum hydroxide, sodium hydrogencarbonate coprecipitate, hydrazine extract, hydrogen Alumina, sodium bicarbonate, magnesium carbonate, precipitated calcium carbonate, precipitated magnesium carbonate, dihydroxy aluminum amine acetate, magnesium hydroxide, magnesium oxide, dried aluminum hydroxide gel, magnesium niobate aluminate, magnesium niobate , synthetic aluminum citrate, thunder hydrochloride Cimetidine (Ranitidine Hydrochloride), cimetidine (Cimetidine), Famotidine, Nizatidine (Nizatidine), Misaki pull nizatidine (Lafutidine), Omeprazole, Lansoprazole,

Pantoprazole、雷貝拉唑鈉(Rrabeprazole sodium )、 Reminoprazole 、 Esomeprazole 、 Pirenzepine Hydrochloride、丙谷胺(proglumide)等。 作爲健胃成份’可舉例如當樂粉末、啤酒花萃取物、 龍膽萃取物、茴香粉末、生薑粉末、.丁香粉末、野桐粉末 、棕兒茶粉末、薑黃粉末、烏梅粉末、烏薬粉末、黃芩粉 末、黄柏粉末、黃蓮粉末、莪朮粉末、葛根粉末、甘草粉 末、枳榖粉末、金雞納樹皮粉末、苦參粉末、肉桂粉末、 決明子粉末、牛兒苗粉末、紅参粉末、厚朴粉末、吳茱 萸粉末、五倍子粉末、非洲防己根粉末、陳皮粉末、山檀 子粉末、花椒粉末、山奈粉末、紫蘇子粉末、縮砂粉末、 小萱蔻粉末、青皮粉末、石菖根粉末、蒼朮粉末、蘇葉粉 末、大黃粉末、竹節人参粉末、雲杉粉末、苦樹粉末、肉 -14- 200812571 登蔻粉末、人參粉末、延命草粉末、蓽茇粉末、白朮粉末 、木香粉末、益智粉末、楊梅皮粉末、薄荷油、龍膽( Gentiana triflora)粉末、良姜粉末、茴香果、蘆薈、睡菜 葉、大茴香、蘿摩(Condurango )、加工大蒜、菖蒲根、 百金、馬錢子萃取物、乾燥酵母、肉鹼鹽酸鹽(Carnitine Hydrochloride)、麩胺酸、Bethanechol chloride、馬來酸 曲美布汀(TrimebutineMaleate)等。Pantoprazole, rabebeprazole sodium, Reminoprazole, Esomeprazole, Pirenzepine Hydrochloride, proglumide, and the like. As a healthy stomach ingredient, for example, Le powder, hop extract, gentian extract, fennel powder, ginger powder, clove powder, wild tung powder, brown catechu powder, turmeric powder, ebony powder, black glutinous powder , Astragalus powder, Cork powder, Huanglian powder, Zhizhu powder, Pueraria powder, licorice powder, glutinous powder, cinchona bark powder, Sophora flavescens powder, cinnamon powder, cassia seed powder, beef seedling powder, red ginseng powder, Magnolia Powder, Wujing powder, gallnut powder, African anti-root powder, dried tangerine powder, mountain sandalwood powder, pepper powder, Shannai powder, perilla powder, sand-reducing powder, small glutinous powder, green skin powder, sarcophagus root powder, atractylodes powder, Suye powder, rhubarb powder, bamboo ginseng powder, spruce powder, bitter tree powder, meat-14- 200812571 Dengqi powder, ginseng powder, diewood powder, glutinous powder, atractylodes powder, woody powder, puzzle powder , bayberry skin powder, peppermint oil, gentian (Gentiana triflora powder), ginger powder, fennel fruit, aloe vera, sleeping leaf, big fennel , Condurango, processed garlic, calamus root, hunter, horseback extract, dried yeast, Carnitine Hydrochloride, glutamic acid, Bethanechol chloride, trimebutine maleate Trimebutine Maleate) and so on.

作爲消化酵素,可舉例如複合型酵素(Biodiastase ) 、脂肪分解酵素 (lipase )、熊去氧膽酸 ( ursodeoxycholic acid)、含糖胃蛋白晦(pepsin)、 Diasmen、纖維酵素(Cellulase) 、Cellulosin、高峰氏澱 粉酶(Taka — Diastase )、膽汁粉末、去氫膽酸( dehydrocholic acid ) 、Newlase、Pancreatin、Biotamilase 、Prozyme、Polypase 等。 作爲黏膜修復成份,可舉例如硫糖鋁(sucralfate )、 Aldioxa、L -麩胺酿胺、索法酮(Sofalcone)、葉綠酸銅 鈉(Sodium copper chlorophyllin )、葉綠酸銅鉀、 CeUaxate Hydrochloride、吉法酯(Gefarnate )、馬來酸 曲美布汀(Trimebutine Maleate ) 、 Sodium azulenesulfonate 等 。 [丙戊酸鈉] 丙戊酸鈉係可依據已知之製造方法而得(例如參考特 開昭60- 1 5 663 8號公報、特開昭62- 1 0604 1號公報、特開 昭63-122646號公報、特開平10-13019 7號公報)。另外 •15- 200812571 ,作爲市售品,例如市售丙戊酸鈉(日本合成化學工業製 ,Alibaba製)等。丙戊酸鈉之配合量係相對於芯材,以1 〜80重量%爲宜,以3 0〜60重量%尤佳。 另外,芯材中除了上述藥物以外,因應需要可配合可 經口投予之各種任意成份。作爲如此可經口投予之各種任 意添加物,可舉例如賦形劑、結合劑、崩壞劑、滑澤劑等 〇 φ 作爲賦形劑,可舉例如乳糖、結晶纖維素、蔗糖、甘 露糖醇、輕質矽酸酐、磷酸氫鈣及玉米澱粉等。 作爲結合劑,可舉例如甲基纖維素、羥丙基纖維素、 羥丙基甲基纖維素、明膠、聚乙烯基吡咯烷酮及普路蘭等 〇 - 作爲崩壞劑,可舉例如 Carmellose calcium、低取代 度經丙基纖維素、Crospovidone 及 Cross Carmellose S odium 等。 • 作爲滑澤劑,可舉例如硬脂酸鎂、硬脂酸鈣及滑石等 〇 本發明之糖衣製劑使用之芯材係可使用藥物及其他任 意成份,由常法製造。 例如爲素錠時,將配合藥物及其他任意添加物造粒後 ’打錠造粒物之方法、或將配合藥物及其他任意添加物造 粒後’以整粒機將此等整粒成粉體後,更因應需要,於該 粉體中添加、混合其他任意添加物之粉體後,將此等粉體 打錠之方法、或直接混合配合藥物及其他任意添加物造粒 -16- 200812571 ,以打錠機進行打錠之方法等。 在此,作爲造粒,可舉例如乾式造粒法及濕式造粒法 ,所謂乾式造粒法係不使用水、乙醇、異丙醇及此等之混 合液等之液體,由乾式造粒機將粉體壓縮成形,製造板狀 固形物後,將此等破壞,製造粒狀物之方法。 另外,所謂濕式造粒法係指使用高速攪拌造粒機、煉 合造粒機、流動層造粒機、轉動流動造粒機等,添加結合 液於粉體,形成粒子後,實施乾燥之方法,結合液的種類 雖無特別的限制,但可使用水、乙醇、異丙醇及此等之混 合液。 接著,芯顆粒時,可舉例如將配合藥物及其他任意添 加物,以乾式造粒法進行顆粒化之方法、濕式造粒法或組 合濕式造粒法與壓出造粒法,進行顆粒化之方法等。 本發明之糖衣製劑所含被覆上述芯材之糖衣層之至少 1層係含0.01〜10重量%之糖及丙烯酸乙酯·甲基丙烯酸 甲酯共聚物爲特徵。 另外,本發明之糖衣製劑係除了使用本發明之糖衣液 所形成之1層或多數層之糖衣層以外,亦可具有以其他被 覆液所形成之1層或多數層之被覆層。另外,本說明書中 ,由本發明之糖衣液所形成的層記載爲「糖衣層」,該糖 衣層及本發明之糖衣液以外之被覆液所形成的層統合記載 爲「被覆層」。 被覆層係可依該功能分爲防水層(protective coating )、粉衣層(subcoating)、平滑層(smoothing)、色衣 -17· 200812571 層(coloring)及磨光層(polishing)等之多數層等。此 等各層對被覆層整體之比率,通常防水層爲0〜20%,粉 衣層爲15〜100%,平滑層爲0〜50%,色衣層爲〇〜50% 及磨光層爲0〜1 0%。防水層係糖衣步驟中用以抑制水份 移動至芯材而實施者。另外,粉衣層係實施用以修整糖衣 錠的形狀者,糖衣錠的外觀、強度之優劣係受到此粉衣層 好壞影響。另外,平滑層係用以使糖衣錠之表面平滑,色 衣層係著色,用以提高糖衣錠之識別性或商品價値,磨光 層係實施用以給予糖衣錠光澤者。本發明之糖衣製劑並非 一定具有擁有上述機能之所有被覆層,但以含具有粉衣層 機能之被覆層爲宜,使用本發明之糖衣液所形成糖衣層係 可適用於作爲具有粉衣層機能之被覆層爲宜。 另外,本發明之糖衣製劑係可因應目的,亦可被覆與 上述被覆層不同之釋出控制層。釋出控制層係實施用以賦 予控制芯材所含藥物溶出之機能者,可爲1層或多數層。 釋出控制層係直接被覆於芯材,或亦可實施於上述之防水 層、粉衣層、平滑層、色衣層及磨光層中任一層間,通常 以被覆於芯材爲宜。被覆釋出控制層時,相對於1重量份 之糖衣製劑係以1〜1 〇重量%爲宜,以2〜8重量%尤佳。 另外,實施釋出控制層之方法或使用成份係可使用常法者 〇 本發明之糖衣製劑中使用本發明之糖衣液所形成糖衣 層之重量係相對於芯材重量,以5〜60重量%爲宜,以1〇 〜50重量%尤佳。糖衣層之重量若超過60重量%時,因爲 200812571 被覆步驟時間長,相對於加入芯材之質量’完成 劑之質量變多,所以發生需要另外的被覆裝置之 外,若未滿5重量%時,不能得到充份之被覆層 另外,因爲被覆層薄,所以發生不能自環境濕度 或芯顆粒等之內容物等之問題。 本發明之糖衣製劑中之吸濕率係於溫濕度 85%,24小時後之條件下,以1.0%以下爲宜,B 下尤佳,於溫濕度爲40 °C -75%,3 0日後之條 4.0%以下爲宜,以3.0%以下尤佳。另外,關於 壞度,因應本發明之糖衣製劑之使用目的或芯材 而可適當調整。 本發明之糖衣製劑之芯材含有大蒜加工物時 劑之硬度係以100N以上爲宜,以110N以上尤 ,崩壞度係以25分鐘以內爲宜。 本發明之糖衣製劑之芯材含有MMSC時係, 之硬度係以65N以上爲宜,以70N以上尤佳。 壞度係以1 5分鐘以內爲宜。 本發明之糖衣製劑之芯材含有丙戊酸鈉時, 之硬度係以65N以上爲宜,以70N以上尤佳。 本發明之糖衣製劑係同時進行本發明之糖衣 步驟、及乾燥步驟之連續被覆法形成糖衣層而可 即,藉由噴霧本發明之糖衣液於含藥物之芯材下 ,使被覆芯材之糖衣液中之溶劑飛散而可形成糖 外,藉由使用之芯材(素錠或芯顆粒),可形成 之糖衣製 問題。另 之硬度, 保護素錠 爲 25°C -乂 0.5 %以 件下,以 硬度或崩 所含藥物 ,糖衣製 佳。另外 糖衣製劑 另外,崩 糖衣製劑 液之噴霧 製造。亦 進行乾燥 衣層。另 糖衣錠或 -19- 200812571 糖衣顆粒之劑形。 製造糖錠時,於連續旋轉之被覆裝置內,加入含藥物 之素錠或對其實施防水層之防護錠’對於裝置內旋轉之素 錠或防護錠,藉由同時進行糖衣液之噴霧及乾燥’可形成 被覆芯材之糖衣層。作爲使用連續被覆法之裝置’可舉例 如 Hicoater ( Freund 產業)、Aqua coater ( Freund 產業) 、Po wr ex coater ( Powrex) 、Dri a coater ( P o w r e x )等。 噴霧糖衣液之液滴徑係以0·1〜ι,〇〇〇μηι爲宜,噴霧 量係因應芯材的大小或量’調節以使展開於芯材表面整體 即可。另外,糖衣液的溫度係以1〇〜8〇°c爲宜。關於給氣 溫度及風量,調節以使製品溫度成爲10〜60°c爲宜。 製造糖衣顆粒時,以使用流動層被覆機進行爲宜,尤 其是使用底部具有旋轉盤之轉動流動層被覆機尤佳。可舉 例如 Multiplex ( Powrex) 、Granurex ( Freund 產業)、 Spir-A-Flow ( Freund 產業)、Agglomaster ( Hosokawa Micron ) 、New/Marumerizer ( Fuj ipaudal )等。 於連續地旋轉本體底面部之被覆裝置內,加入含藥物 之顆粒或對其實施防水層等之防護顆粒,對於裝置內流動 及旋轉之顆粒或防護顆粒,同時進行糖衣液之噴霧及乾燥 ,可形成被覆芯材之糖衣層。 噴霧糖衣液之液滴徑係以0.1〜100μπι爲宜,噴霧量 係因應芯材的大小或量,調節以使展開於芯材表面整體即 可。另外,糖衣液的溫度係以1 0〜8 0 °C爲宜。關於給氣溫 度及風量,調節以使製品溫度成爲1 0〜5 (TC爲宜。 -20- 200812571 另外,由本發明之糖衣液以外之被覆液形成被覆層係 可以製造糖衣製劑一般所使用之方法進行。此時使用之被 覆裝置亦可依被覆液的種類等適當選擇使用,並無特別的 限制。另外,關於噴霧被覆液時之液滴或噴霧量,可與糖 衣液之噴霧同樣地調節。 如此所得之本發明之糖衣製劑與傳統的製劑相比較, 糖衣層薄,具有充份的硬度,而且低吸濕性、防臭性及崩 壞性亦優異。 【實施方式】 實施例 以下係使用實施例具體地說明本發明。 &lt;製造例1 &gt; 加入3000g之乳糖、150g之羥丙基纖維素(HPC_L: 日本曹達)、1 200g之玉米澱粉、lOOOg之結晶纖維素( CeolusPH-101 :旭化成)於高速攪拌造粒機(VG-25 : Powrex ),加入精製水調製造粒物。將其以流動層乾燥機 (FLO-5B : Freund產業)乾燥後,以整粒機(Power mill ,昭和化學機械)將乾燥物整粒。 混合50g之硬脂酸鎂於53 50g之所得之整粒物,將其 以滾輪式打錠機(HP-A18_SS :畑鐵工所),製造每1錠 爲270mg之素錠。 於5400g之所得之素錠中,使用由l〇〇g之羥丙基甲 -21 - 200812571 基纖維素2 910(TC-5R:信越化學工業)及900g之精製 水而成之被覆液,以被覆機(Dria coater DRC— 650 ’ Powrex)施以防水層於素錬,製造每1銳爲275mg之防g蒦 錠。 &lt;實施例1 &gt; 於5 500g之製造例1所得之防護錠,使用由1180g之 白砂糖、400g之滑石、400g之沈澱碳酸鈣、66.7g之丙烯 酸乙酯·甲基丙烯酸甲酯共聚物 30%分散液 ( EudragitNE3 0D :樋口商會)及 2 0 0 0 g之精製水而成之懸 浮糖衣液,以被覆機(Dria coater DRC — 650,Powrex) 噴霧糖衣液下進行乾燥,得到每1錠爲3 75mg之糖衣錠。 另外,被覆作業所費時間爲2小時。 &lt;實施例2 &gt; 於5 500g之製造例1所得之防護錠,使用由1160 g之 白砂糖、400g之滑石、400g之沈澱碳酸鈣、133.3§之丙 烯酸乙酯·甲基丙烯酸甲酯共聚物 3 0%分散液( EudragitNE30D :樋口商會)及2 0 0 0 g之精製水而成之懸 浮糖衣液,以被覆機(Dria coater DRC — 65 0,Powrex ) 噴霧糖衣液下進行乾燥,得到每1錠爲375mg之糖衣錠。 另外,被覆作業所費時間爲2小時。 &lt;實施例3 &gt; -22- 200812571 於5 500g之製造例1所得之防護錠,使用由1120g之 白砂糖、400g之滑石、400g之沈澱碳酸鈣、266.7g之丙 烯酸乙酯·甲基丙烯酸甲酯共聚物 3 0%分散液( EudragitNE30D:樋口商會)及2000g之精製水而成之懸 浮糖衣液,以被覆機(Dria coater DRC — 650,Powrex ) 噴霧糖衣液下進行乾燥,得到每1錠爲3 75 mg之糖衣錠。 另外,被覆作業所費時間爲2小時。 &lt;比較例1 &gt; 於5 500g之製造例1所得之防護錠,使用由1160g之 白砂糖、400g之滑石、400g之沈澱碳酸鈣、40g之羥丙基 甲基纖維素2910(TC-5R:信越化學工業)及2000g之精 製水而成之懸浮糖衣液,以被覆機(Dria coater DRC — 65 0,Powrex )噴霧糖衣液下進行乾燥,得到每1錬爲 3 75 mg之糖衣錠。另外,被覆作業所費時間爲2小時。 &lt;比較例2 &gt; 於5 500g之製造例1所得之防護錠,使用由1 924g之 白砂糖、542g之滑石、81 8g之沈澱碳酸鈣、64g之阿拉伯 膠、3〇g之明膠、22g之聚環氧乙烷(105)聚環氧丙烷( 5 )乙二醇(PEP-101 : Freund產業)及1200g之精製水而 成之懸浮糖衣液,以被覆機(Dria coater DRC— 650, Powrex),分別進行糖衣液之噴霧、蒸煮、乾燥之傳統的 糖衣被覆方法,得到每1錠爲44 5 mg之糖衣錠。另外,被 -23 - 200812571 覆作業所費時間爲6.5小時。 &lt;製造例2 &gt; 力U入5 00g之大蒜加工物(Oxoamidine,理硏化學工 業(股)製)、2500g之乳糖、150g之羥丙基纖維素( HPC-L :日本曹達)、1200g之玉米澱粉、l〇〇〇g之結晶纖 維素(CeolusPH-101:旭化成)於高速攪拌造粒機(乂〇_ 25 : Powrex ),加入精製水調製造粒物。將其以流動層乾 燥機(FLO-5B : Freund產業)乾燥後,以整粒機(Power mill,昭和化學機械)將乾燥物整粒。 混合50g之硬脂酸鎂於53 50g之所得之整粒物’將其 以滾輪式打錠機(HP-AP18-SS :畑鐵工所),製造每1錠 爲270mg之素錠。 於5400g之所得之素錠中,使用l〇〇g之羥丙基甲基 纖維素2910(TC-5R:信越化學工業)及90 0g之精製水 而成之被覆液,以被覆機(Dria coater DRC— 650, Powrex)施以防水層於素錠,製造每1錠爲2 75mg之防護 錠。 &lt;實施例4 &gt; 於5 5 00g之製造例2所得之防護錠,使用由1180g之 白砂糖、400g之滑石、40 0g之沈澱碳酸鈣、66.7g之丙烯 酸乙酯·甲基丙烯酸甲酯共聚物 30%分散液( EudragitNE30D:樋口商會)及2000g之精製水而成之懸 -24- 200812571 浮糖衣液,以被覆機(Dria coater DRC — 650,Powrex) 噴霧糖衣液下進行乾燥,得到每1錠爲375mg之糖衣銳。 另外,被覆作業所費時間爲2小時。 &lt;實施例5 &gt; 於5 500g之製造例2所得之防護錠,使用由1160g之 白砂糖、400g之滑石、400g之沈澱碳酸鈣、133.3g之丙 烯酸乙酯·甲基丙烯酸甲酯共聚物 30%分散液( EudragitNE3 0D :樋口商會)及20 00 g之精製水而成之懸 浮糖衣液,以被覆機(Dria coater DRC — 650,Powrex) 噴霧糖衣液下進行乾燥,得到每1錠爲3 75mg之糖衣錠。 另外,被覆作業所費時間爲2小時。 &lt;實施例6 &gt; 於5 500g之製造例2所得之防護錠,使用由1120 g之 白砂糖、400g之滑石、400g之沈澱碳酸鈣、266.7g之丙 烯酸乙酯·甲基丙烯酸甲酯共聚物 3 0%分散液( EudragitNE30D :樋口商會)及2 0 0 0 g之精製水而成之懸 浮糖衣液,以被覆機(Dria coater DRC — 650,Powrex) 噴霧糖衣液下進行乾燥,得到每1錠爲3 7 5mg之糖衣錠。 另外,被覆作業所費時間爲2小時。 &lt;比較例3〉 於5 500g之製造例2所得之防護錠,使用由1 160g之 25- 200812571 白砂糖、400g之滑石、之沈殿碳酸銘、之羥丙基 甲基纖維素2910 ( TC-5R ·_信越化學工業)及2000g之精 製水而成之懸浮糖衣液’以被覆機(Dria coater DRC 一 6 5 0,P o w r e x )噴霧糖衣液下進订乾燥’得到每1銳爲 3 7 5 m g之糖衣錠。另外,被覆作業所費時間爲2小時。 &lt;比較例4 &gt; φ 於5 500g之製造例2所得之防護錠,使用由1 924g之 白砂糖、542g之滑石、818g之沈澱碳酸鈣、64g之阿拉伯 膠、30g之明膠、22g之聚環氧乙烷(105)聚環氧丙烷( 5 )乙二醇(PEP-1 0 1 : Freund產業)及1 200g之精製水而 成之懸浮糖衣液,以被覆機(Dria coater DRC — 65 0, P o w r e x ),分別進行糖衣液之噴霧、蒸煮、乾燥之傳統之 糖衣被覆方法,得到每1錠爲445111§之糖衣錠。另外,被 覆作業所費時間爲6.5小時。 &lt;製造例3 &gt; 加入l〇〇〇g之氯化甲硫胺基酸(氯化甲硫胺基酸,米 澤濱理藥品)、600g之乳糖、300 g之聚乙烯基吡咯烷酮 (CoridonSO : BASF 日本)、1550g 之玉米澱粉、500g 之 CarmeUose calcium ( ECG-5 05 :五德藥品)於高速攪拌造 粒機(VG-25 : Powrex ),加入乙醇調製造粒物。將其以 流動層乾燥機(FLO-5B ·· Freund產業)乾燥後,以整粒 機(Power mill,昭和化學機械)將乾燥物整粒。 -26- 200812571 混合50g之硬脂酸鎂於39 5 0g之所得之整粒物,將其 以滾輪式打錠機(HP-AP18-SS :畑鐵工所),製造每1錠 爲lOOmg之素錠。 於4000g之所得之素錠中,使用溶解400g之硬化油 、100g之單硬脂酸甘油酯(NikkolMGS-B:日光化學)及 100g之單硬脂酸聚乙二醇(40EO) (NikkolMYS-40:日 光化學)於600mL之乙醇液、及200g之滑石,以被覆機 (Dria coater DRC 一 650,Powrex)施以防水層於素銳, 製造每1錠爲120mg之防護錠。 &lt;實施例7 &gt; 於4800g之製造例3所得之防護錠,使用由1180g之 白砂糖、400g之)骨石、400g之沈澱碳酸鈣、66.7g之丙烯 酸乙酯·甲基丙烯酸甲酯共聚物 30%分散液( EudragitNE30D :樋口商會)及2 0 0 0 g之精製水而成之懸 浮糖衣液,以被覆機(Dria coater DRC — 650,Powrex) 噴霧糖衣液下進行乾燥,得到每1鏡爲1 7 0 m g之糖衣錠。 另外,被覆作業所費時間爲1小時。 &lt;實施例8 &gt; 於4 800g之製造例3所得之防護錠,使用由1160g之 白砂糖、400g之滑石、400g之沈澱碳酸鈣、133.3g之丙 烯酸乙酯·甲基丙烯酸甲酯共聚物 30%分散液( EudragitNE30D :樋口商會)及2000g之精製水而成之懸 -27- 200812571 浮糖衣液,以被覆機(Dria coater DRC — 650,Powrex) 噴霧糖衣液下進行乾燥,得到每1錠爲1 70mg之糖衣錠。 另外,被覆作業所費時間爲1小時。 &lt;實施例9 &gt; 於4 800g之製造例3所得之防護錠,使用由1 120g之 白砂糖、400g之滑石、400g之沈澱碳酸鈣、266.7g之丙 烯酸乙酯·甲基丙烯酸甲酯共聚物 30%分散液( EudragitNE30D :樋口商會)及2000g之精製水而成之懸 浮糖衣液’以被覆機(D r i a c o a t e r D R C — 65 0 ’Powrex) 噴霧糖衣液下進行乾燥,得到每1錠爲170mg之糖衣錠。 另外,被覆作業所費時間爲1小時。 &lt;比較例5 &gt; 於4 800g之製造例3所得之防護錠,使用由1160g之 白砂糖、400g之滑石、400g之沈澱碳酸鈣、40g之羥丙基 甲基纖維素2910(TC-5R:信越化學工業)及2000g之精 製水而成之懸浮糖衣液,以被覆機(〇1^(:〇3161〇11€: — 6 5 0,P 〇 w r e X )噴霧糖衣液下進行乾燥,得到每1錠爲 170mg之糖衣錠。另外,被覆作業所費時間爲1小時。 &lt;比較例6&gt; 於48 00g之製造例3所得之防護錠,使用由6〇Og之 白砂糖、1100g之滑石、1100g之沈澱碳酸鈣、280g之阿 -28- 200812571 拉伯膠、60g之明膠及600g之精製水而成之懸浮糖衣液’ 以被覆機(Dria coater DRC— 650,Powrex ) ’ 分別進行 糖衣液之噴霧、蒸煮、乾燥之傳統之糖衣被覆方法’得到 每1錠爲200mg之糖衣錠。另外,被覆作業所費時間爲 3.5小時。 &lt;製造例4 &gt; 加入3300g之丙戊酸鈉、165g之輕質矽酸酐及 3 03.6g之乙基纖維素於高速攪拌造粒機(VG-25 : Powrex ),加入乙醇調製造粒物。將其以流動層乾燥機(FL〇_5B :Freund產業)乾燥後,以整粒機(Power mill,昭和化 學機械),將乾燥物整粒。 混合24g之硬脂酸鈣於342 6g之所得之整粒物’將此 以滾輪式打錠機(HP-AP1 8-SS :畑鐵工所)’製造每1錠 爲23 0mg之素錠。 於3220g之所得之素錠中,使用溶解、分散6〇g之乙 基纖維素、30g之甲基丙烯酸共聚物L(EudragitL100:樋 口商會)、22.5g之檸檬酸三乙酯及22.5g之輕質砂酸酐 於1365g之乙醇液,以被覆機(Dria coaterDRC — 650’ Powrex )施以釋出控制層於素錠後,再使用溶解.、分散 60g之乙基纖維素及3〇g之輕質矽酸酐於1410g之乙醇液 ,以被覆機(Dria coater DRC— 65 0,Powrex )施以釋出 控制層,製造每1錠爲245mg之釋出控制錠。 -29 - 200812571 &lt;實施例1 〇 &gt; 於6 86g之製造例4所得之釋出控制錠,使用由 之白砂糖、3g之滑石、51g之沈澱碳酸鈣、9.9g之丙 乙酯·甲基丙烯酸甲酯共聚物 3〇%分散 EudragitNE30D :樋口商會)及135.6g之精製水而成 浮糖衣液,以被覆機(Hicoater HCT— 30N,Freund )噴霧糖衣液下進行乾燥,得到每1錠爲295mg (其 衣層之質量爲5 Omg )之糖衣錠。另外,被覆作業所 間爲40分鐘。 &lt;實施例1 1 &gt; 於68 6g之製造例4所得之釋出控制錠,使用由 之白砂糖、6g之滑石、102g之沈澱碳酸鈣、20.1g之 酸乙酯·甲基丙烯酸甲酯共聚物 30%分散 EudragitNE30D :樋口商會)及270.9g之精製水而成 浮糖衣液,以被覆機(Hicoater HCT— 30N,Freund )噴霧糖衣液下進行乾燥,得到每1錠爲3 45mg (其 衣層之質量爲l〇〇mg )之緩釋性糖衣錠。另外,被覆 所費時間爲75分鐘。 &lt;比較例7 &gt; 於68 6g之製造例4所得之釋出控制錠,使 2 8 8.6 g之白砂糖、8 1 . 3 g之滑石、:1 2 2.7 g之沈澱碳酸 9 · 6 g之阿拉伯膠、4 · 5 g之明膠、3 . 3 g之聚環氧乙烷 93g 烯酸 t ( 之懸 產業 中糖 費時 186g 丙烯 液( 之懸 產業 中糖 作業 用由 鈣、 -30 - (105 200812571 )聚環氧丙烷(5 )乙二醇及180g之精製水而成之懸浮糖 衣液,以小型糖衣機(菊水製作所製)’分別進行糖衣液 之噴霧、蒸煮、乾燥之傳統之糖衣被覆方法’得到每1錠 爲41 5mg之粉衣錠。另外,此被覆作業所費時間爲3 00分 鐘。進而,使用由114g之白砂糖、6g之氧化鈦及72g之 精製水而成之懸浮糖衣液,以小型糖衣機(菊水製作所製 ),分別進行糖衣液之噴霧、蒸煮、乾燥之傳統之糖衣被 覆方法,得到每1錠爲45 5mg之色衣錠。另外,此被覆作 業所費時間爲240分鐘。最後,使用由15g之白砂糖及9g 之精製水而成之糖衣液,以小型糖衣機(菊水製作所製) ,分別進行糖衣液之噴霧、蒸煮、乾燥之傳統之糖衣被覆 方法,得到每1錠爲460mg(其中糖衣層之質量爲215mg )之糖衣錠。另外,此被覆作業所費時間爲3 0分鐘,全 部的被覆作業所費時間合計爲570分鐘。 由上述結果可知使用同時進行噴霧、乾燥糖衣液之本 發明之製造方法,與傳統之被覆方法相比較,可縮短作業 時間成3分之1以下。另外,亦可知糖衣錠中糖衣層之重 量亦可成爲2分之1〜4分之1之程度。 &lt;評估吸濕性&gt; 將實施例1〜9、比較例1〜6所得之糖衣錠1 0錠,以 25°C -84.3%之條件,測定靜置1小時、2小時、3小時及 24小時後之質量,與開始時之質量進行比較,測定吸濕量 ’算出吸濕率(% )。另外,將實施例1 0〜1 1、比較例7 -31 200812571 所得之糖衣錠1 0錠’以4 0 °c -7 5 %之條件’測定靜置3小 時、1天、2天、3天、7天、10天、14天、21天、28天 及3 〇天後之質量,與上述同樣地算出吸濕率(% )。結果 如圖1〜4所示。 吸濕率(% )=(保管各時間後之1 〇錠錠劑質量-開 始時之1〇錠錠劑質量)/開始時之10錠錠劑質量xl 00 依據圖1,實施例1〜3之糖衣製劑即使於上述條件下 靜置24小時,吸濕率仍低,爲〇·1%。比較例1之糖衣製 劑於靜置3小時時,吸濕率成爲0.2%,靜置24小時時, 吸濕率增加至近於1 .2%。另外,比較例2之糖衣製劑於 靜置24小時時,吸濕率增加至0.5 %程度。 依據圖2,實施例4〜6之糖衣製劑即使於上述條件下 靜置24小時,吸濕率仍低,爲0.1 %。比較例3之糖衣製 劑於靜置3小時時,吸濕率成爲0.4%,靜置24小時時, 吸濕率增加至近於2 · 1 %。另外,比較例4之糖衣製劑於 靜置24小時時,吸濕率增加至0.5 %程度。 依據圖3,實施例7〜9及比較例6之糖衣製劑即使於 上述條件下靜置24小時,吸濕率仍低,爲0.5 %以下。比 較例5之糖衣製劑於靜置3小時時,吸濕率增加至近於 1 . 3 %,靜置2 4小時時,增加至近於5.6 %。 依據圖4,實施例10及1 1之糖衣製劑,即使糖衣層 之質量與比較例7相比較,分別約爲4分之1及2分之1 ,於30天後之吸濕率仍極低,分別爲2.0 %及1.0 %以下。 相對之下,比較例7之糖衣製劑,於7天後之階段,吸濕 -32- 200812571 率近於4.0%,進而,於1 0天後,錠劑破裂。推測錠劑破 裂係因丙戊酸鈉之吸濕性。 由以上可知,若使用本發明之糖衣液,即使藉由噴霧 糖衣液下乾燥之被覆方法,製造糖衣製劑時,與傳統之糖 衣製劑相比較,可得到低吸濕性之優異糖衣製劑。 &lt;評估物性&gt; 測定實施例1〜9、比較例1〜6所得之糖衣錠之硬度 及崩壞度。硬度係採取 20錠,以錠劑硬度計( PHARMATEST社製ΡΤΒ-311Ε)測定每1錠之錠劑硬度, 算出平均値。崩度係依據日本藥局方第15改正所記載之 崩壞試驗法,使用補助盤測定(富山產業社製崩壞試驗 器)。試驗係對6錠進行,算出平均値。結果如表1〜3 所示。 [表1] 實施例1 實施例2 實施例3 比較例1 比較例2 硬度(N) 120.2 148.6 116.1 71.6 142.7 崩壞度(份) 22.4 21.0 20.6 29.9 30.9 實施例1〜3之糖衣製劑具有充份的硬度,並且,崩 壞性亦優異。另一方面,比較例i之糖衣製劑的硬度及崩 壞性均不足。比較例2之糖衣製劑雖具有高硬度,但崩壞 性不足。 -33- 200812571 [表2] 表2 實施例4 實施例5 實施例6 比較例3 比較例4 硬度(N) 118.5 120.3 125.8 91.8 138.5 崩壞度(份) 20.5 22.3 21.9 28.3 32.1 實施 例 4〜6 之 糖衣製劑具有充份 的硬度, 並且,崩 壞性亦優 異 〇另一 方 面,比較例3之糖 :衣製劑的 硬度及崩 壞性均不 足 。比較 例 4之糖; 夜製劑雖具 .有高硬度 ,但崩壞 性不足。 [表3] 表3 實施例7 實施例8 實施例9 比較例5 比較例6 硬度(N) 72.8 76.5 81.8 59.8 92.9 崩壞度(份) 12.1 11.5 12.2 11.9 18.5 實施例7〜9之糖衣製劑具有充份的硬度,並且,崩 壞性亦優異。另一方面,比較例5及6之糖衣製劑的硬度 及崩壞性均不足。 由以上可知本發明之糖衣製劑具有充份的硬度,並且 ,崩壞性亦優異。 &lt;評估臭味&gt; 評估關於實施例4〜9、比較例3〜6所得之糖衣錠的 臭味。密封所得之製劑於透明玻璃瓶後,於60°C之條件下 ,對於保存3天、1週或2週時發生的臭味,以〇 :完全 -34- 200812571 未感受到來自藥物的不愉快臭味、1 :幾乎未感受到來自 藥物的 不愉 快臭味、 2 :感受 :到來自藥物的不愉快臭味、3 :強烈 感受: 到來自藥 丨物的不愉快臭味之 4階段評估 。評估 係由5 人進: 行,算出 f平均値 。結果如表 4〜5表示。 [表4] 表 4 實施例4 實施例5 實施例6 比較例3 比較例4 剛製造後 0 0 0 0 0 3天後 0 0 0 1.2 0 1週後 0 0 0 2.6 0 2週後 0 0 0 3.0 0 實 施例 4〜6及 比較例 4之糖衣製 劑即使經過 2週之 保存期 間, 完全未感受到來 自 Oxoami dine的不愉 快臭味 。另一 ‘方面 丨,比較 例3之 糖衣製劑 係強烈感受 到來自 Oxoam i dine 的不愉快臭味。 尤其,可知隨著保存長 ^期化, 不愉快臭味變強。 [表5] 表 5 __一^-- 實施例7 實施例8 實施例9 比較例5 比較例6 — 剛製造後 0 0 0 0 0 3天後 0 0 0 2.2 0 1週後 0.4 0.4 0.6 3.0 1.2 2週後 1.2 1.4 1.4 3.0 1.4 實施例 7〜9 及比較例6 之糖衣製劑即使經過 2週之 保存期間, 完全未感受到來自 MMSC 的不愉快臭味 。另一 -35- 200812571 方面,比較例5之糖衣製劑係3天後感受到來自MMSC的 不愉快臭味,1週後強烈感受到不愉快臭味。 由以上可知本發明之糖衣製劑與傳統的糖衣製劑相比 較,防臭性優異。 &lt;評估剛製造後之水分値&gt; 粉碎剛製造後之實施例7〜9 :比較例5〜6之糖衣錠 ,量取約5 g,使用氫氧化鈣作爲反應試劑,由氣壓水分計 測定1 〇分鐘,算出水分値(% )。結果如表6所示° [表6] 表6___ _實施例7 實施例8 實施例9 比較例5 比較例β 水分値(%) 1.65_L55_L62_L56_2.48 實施例7〜9及比較例5之糖衣製劑之水分値(% )與 比較例6之糖衣製劑相比較,數値低。因此,可知使用連 續被覆方法時,與傳統之被覆方法相比較,可降低錠劑中 之水分値。 &lt;溶出試驗&gt; 進行實施例1 1之糖衣錠之溶出試驗。試驗係依據曰 本藥局方溶出試驗法第二法(攪煉)法,使用500mL之曰 局一般試驗法崩壞試驗法第2液作爲試驗液,以每分鐘 10Orpm進行。每各個時間採樣,以HPLC定量採樣溶液中 之丙戊酸鈉含量,算出丙戊酸鈉之溶出率(% )。結果如 _ 36 - 200812571 圖5所示。 由圖5可知,本發明之糖衣製劑之緩釋性亦優異。依 據上述,本發明之糖衣液係有效地用於要求緩釋性藥物之 糖衣製劑化。 由以上可知,本發明之糖衣製劑係由連續被覆法所製 造,與傳統之糖衣製劑相比較,具有充份的硬度,而且, 低吸濕性、防臭性優異之製劑,與由糖衣被覆法所製造之 傳統的糖衣製劑相比較,可以短時間之被覆作業製造,剛 製造後的水分値低,崩壞性優異之製劑。 亦即,由本發明之製造方法,即使糖衣層薄,仍具有 充份的硬度,而且,可短時間且簡易地製造剛製造後之低 水分性、低吸濕性、崩壞性、防臭性優異之糖衣製劑。 [產業上利用性] 使用本發明之糖衣液,可藉由同時進行糖衣液之噴霧 步驟、及乾燥步驟之連續被覆法,進行製造糖衣製劑。亦 即,無需煩雜的步驟,可以短時間製造低透氧性、低吸濕 性、防臭性、崩壞性優異之糖衣製劑。另外,因爲本發明 之製造方法係可形成薄的糖衣層,所以大大地幫助糖衣液 使用量之削減、製劑之小型化。 【圖式簡單說明】 [圖1 ]表示經過時間及糖衣製劑之吸濕率變化圖。 [圖2]表示經過時間及含有大蒜加工物之糖衣製劑之 -37- 200812571 吸·濕率變化圖。 [圖3]表示經過時間及含有MMSC之糖衣製劑之吸濕 率變化圖。 [圖4]表示經過時間及含有丙戊酸鈉之糖衣製劑之吸 濕率變化圖。 [圖5]表示經過時間及丙戊酸鈉之溶出率變化圖。Examples of the digestive enzyme include a compound enzyme (Biodiastase), a lipase, a ursodeoxycholic acid, a pepsin, a Diasmen, a cellulase, and a Cellulosin. Peak amylase (Taka — Diastase), bile powder, dehydrocholic acid, Newlase, Pancreatin, Biotamilase, Prozyme, Polypase, etc. As the mucosa repairing component, for example, sucralfate, Aldioxa, L-glutamine, Sofalcone, sodium copper chlorophyllin, potassium chlorophyllin, CeUaxate Hydrochloride , Gefarnate, Trimebutine Maleate, Sodium azulenesulfonate, and the like. [Sodium valproate] The sodium valproate system can be obtained according to a known production method (for example, Japanese Laid-Open Patent Publication No. SHO 60-165 663, JP-A-62-110604, JP-A-63- Japanese Patent Publication No. 122646 and Japanese Patent Laid-Open No. Hei 10-13019 No. 7). In addition, 15-200812571 is commercially available, for example, sodium valproate (manufactured by Nippon Synthetic Chemical Industry Co., Ltd., Alibaba). The amount of sodium valproate is preferably from 1 to 80% by weight, more preferably from 30 to 60% by weight, based on the core material. Further, in addition to the above-mentioned drugs, the core material may be blended with any of the various components which can be orally administered as needed. Examples of the various additives which can be administered orally, such as excipients, binders, disintegrators, and slip agents, may be used as excipients, and examples thereof include lactose, crystalline cellulose, sucrose, and mannose. Sugar alcohol, light phthalic anhydride, calcium hydrogen phosphate and corn starch. Examples of the binder include, for example, methylcellulose, hydroxypropylcellulose, hydroxypropylmethylcellulose, gelatin, polyvinylpyrrolidone, and sulphate, as a breaker, and for example, Carmellose calcium, Low substitutions include propylcellulose, Crospovidone, and Cross Carmellose Sodium. • The slip agent may, for example, be magnesium stearate, calcium stearate or talc. The core material used in the sugar coating preparation of the present invention can be produced by a usual method using a drug and other optional ingredients. For example, in the case of a plain ingot, the method of granulating the drug and any other additives, or the method of granulating the compounding drug and any other additives, and then granulating the powder into a powder by a granulator After the body is added, the powder of any other additives may be added or mixed in the powder, and the powder may be ingot or directly mixed with the drug and any other additives to granulate-16-200812571 , the method of ingoting by a tablet machine, and the like. Here, examples of the granulation include a dry granulation method and a wet granulation method, and the dry granulation method does not use a liquid such as water, ethanol, isopropyl alcohol or a mixed liquid thereof, and is granulated by dry granulation. A method in which a powder is compression-molded to produce a plate-like solid, which is then destroyed to produce a granular material. In addition, the wet granulation method refers to the use of a high-speed stirring granulator, a kneading granulator, a fluidized bed granulator, a rotary flow granulator, etc., and a binder is added to the powder to form particles, and then dried. The method, the type of the binding liquid is not particularly limited, but water, ethanol, isopropyl alcohol, and the like can be used. Next, in the case of the core particles, for example, a method of granulating a compounded drug and any other additives by a dry granulation method, a wet granulation method or a combined wet granulation method and extrusion granulation method, and granules are carried out. Method of chemistry, etc. The sugar-coated preparation of the present invention comprising at least one layer of the sugar-coated layer covering the core material is characterized by comprising 0.01 to 10% by weight of a sugar and an ethyl acrylate-methyl methacrylate copolymer. Further, the sugar-coating preparation of the present invention may have a coating layer of one layer or a plurality of layers formed of another coating liquid in addition to the sugar coating layer of one layer or a plurality of layers formed by the sugar coating liquid of the present invention. In the present specification, the layer formed of the sugar coating liquid of the present invention is referred to as a "sugar coating layer", and the layer formed of the coating layer other than the sugar coating layer of the present invention is described as a "coating layer". The coating layer can be classified into a plurality of layers such as a protective coating, a subcoating, a smoothing, a coloring -17·200812571 coloring, and a polishing layer according to the function. Wait. The ratio of the layers to the entire coating layer is usually 0 to 20% for the waterproof layer, 15 to 100% for the powder coating layer, 0 to 50% for the smooth layer, 〇~50% for the color coat layer and 0 for the polishing layer. ~1 0%. The waterproof layer is used in the sugar coating step to inhibit the movement of moisture to the core material. Further, the powder coating layer is used to trim the shape of the sugar-coated ingot, and the appearance and strength of the sugar-coated tablet are affected by the quality of the coating layer. Further, the smoothing layer is used to smooth the surface of the sugar-coated ingot, and the coloring layer is colored to enhance the visibility of the sugar-coated ingot or the commercial price, and the polishing layer is applied to impart gloss to the sugar-coated lozenge. The sugar-coated preparation of the present invention does not necessarily have all the coating layers having the above functions, but it is preferable to use a coating layer having a function of a coating layer, and the coating layer formed by using the coating liquid of the present invention can be suitably used as a coating layer function. The coating layer is suitable. Further, the sugar-coating preparation of the present invention may be coated with a release control layer different from the above-mentioned coating layer depending on the purpose. The release control layer may be one or more layers for performing functions for imparting dissolution of the drug contained in the control core material. The release control layer is directly coated on the core material, or may be applied between any of the above-mentioned waterproof layer, powder coating layer, smoothing layer, color coating layer and polishing layer, and is usually coated on the core material. When the control layer is released, it is preferably 1 to 1% by weight, more preferably 2 to 8% by weight, based on 1 part by weight of the sugar coating preparation. In addition, the method of using the release control layer or the component can be used, and the weight of the sugar coating layer formed by using the sugar coating liquid of the present invention in the sugar coating preparation of the present invention is 5 to 60% by weight based on the weight of the core material. It is preferable to use 1 〇 to 50% by weight. If the weight of the sugar-coated layer exceeds 60% by weight, since the coating step of 200812571 is long, the quality of the finished agent is increased with respect to the quality of the core material to be added, so that if another coating device is required, if it is less than 5% by weight In addition, since a sufficient coating layer is not obtained, since the coating layer is thin, there is a problem that contents such as environmental humidity or core particles cannot be obtained. The moisture absorption rate in the sugar coating preparation of the invention is 85% under the condition of temperature and humidity, and is preferably 1.0% or less under the condition of 24 hours, especially preferably B, and the temperature and humidity are 40 ° C -75%, 30 days later. The article is preferably 4.0% or less, and preferably 3.0% or less. Further, the degree of the damage can be appropriately adjusted in accordance with the purpose of use or the core material of the sugar-coated preparation of the present invention. When the core material of the sugar-coating preparation of the present invention contains a garlic processed product, the hardness of the agent is preferably 100 N or more, more preferably 110 N or more, and the degree of collapse is preferably within 25 minutes. When the core material of the sugar-coating preparation of the present invention contains MMSC, the hardness is preferably 65 N or more, and more preferably 70 N or more. The degree of badness is within 15 minutes. When the core material of the sugar-coating preparation of the present invention contains sodium valproate, the hardness is preferably 65 N or more, and more preferably 70 N or more. The sugar coating preparation of the present invention is obtained by simultaneously performing the sugar coating step of the present invention and the continuous coating method of the drying step to form a sugar coating layer, that is, by spraying the sugar coating liquid of the present invention under the drug-containing core material to coat the sugar coating of the core material. The solvent in the liquid scatters to form a sugar, and the core material (primary ingot or core particle) can be used to form a sugar coating problem. In addition, the hardness of the protective ingot is 25 ° C - 乂 0.5 %, and the hardness or the disintegration of the drug is good. In addition, the sugar-coated preparation is additionally produced by spraying a sugar-coated preparation liquid. The coat layer is also dried. Another sugar-coated tablets or -19- 200812571 sugar-coated granules. In the manufacture of a sugar ingot, a protective ingot containing a drug-containing ingot or a water-repellent layer is added to the continuous rotating coating device. For the spinning of the ingot or the protective ingot in the device, the spraying and drying of the sugar coating liquid is simultaneously performed. 'The sugar coating layer of the coated core material can be formed. As a device using the continuous coating method, for example, Hicoater (Freund Industries), Aqua coater (Freund Industries), Po wr ex coater (Powrex), Dri a coater (P o w r e x ), and the like can be exemplified. The droplet diameter of the spray coating liquid is preferably 0.1 to ι, 〇〇〇μηι, and the spray amount is adjusted according to the size or amount of the core material so as to be spread over the entire surface of the core material. Further, the temperature of the sugar coating liquid is preferably from 1 〇 to 8 〇 ° c. Regarding the temperature of the feed gas and the amount of the air, it is preferable to adjust the temperature of the product to 10 to 60 ° C. In the case of producing the sugar-coated granules, it is preferred to use a fluidized bed coating machine, in particular, a rotating fluidized bed coating machine having a rotating disk at the bottom is particularly preferred. For example, Multiplex (Powrex), Granurex (Freund Industries), Spir-A-Flow (Freund Industries), Agglomaster (Hosokawa Micron), New/Marumerizer (Fuj ipaudal), and the like. In the coating device for continuously rotating the bottom surface of the body, the particles containing the drug or the protective particles of the waterproof layer or the like are added, and the particles and the protective particles flowing and rotating in the device are simultaneously sprayed and dried by the sugar coating liquid. A sugar coating layer covering the core material is formed. The droplet diameter of the spray coating liquid is preferably 0.1 to 100 μm, and the amount of spray is adjusted according to the size or amount of the core material so as to be spread over the entire surface of the core material. Further, the temperature of the sugar coating liquid is preferably from 10 to 80 °C. The temperature of the feed gas and the amount of the air are adjusted so that the temperature of the product becomes 10 to 5 (TC is preferably -20-200812571. Further, the coating layer other than the coating liquid of the present invention can be used to form a coating system. The coating device to be used in this case can be appropriately selected and used depending on the type of the coating liquid, etc., and the amount of droplets or spray when the coating liquid is sprayed can be adjusted in the same manner as the spraying of the sugar coating liquid. The sugar-coated preparation of the present invention thus obtained has a thin sugar coating layer and a sufficient hardness as compared with the conventional preparation, and is also excellent in low hygroscopicity, odor resistance, and chipping property. The present invention will be specifically described. <Production Example 1> 3000 g of lactose, 150 g of hydroxypropylcellulose (HPC_L: Japan Soda), 1 200 g of corn starch, and 1000 g of crystalline cellulose (Cesolus PH-101: Asahi Kasei) were added. In a high-speed stirring granulator (VG-25: Powrex), fine water is added to prepare the granules, which are dried in a fluidized bed dryer (FLO-5B: Freund Industries). Machine (Power mill, Showa Chemical Machinery) granules the dried product. Mix 50g of magnesium stearate with 53 50g of the whole granules, and use it as a roller type ingot machine (HP-A18_SS: 畑铁工所) Manufactured as a 270 mg per ounce of ingot per liter. In 5400 g of the obtained ingot, hydroxypropylmethyl-21 - 200812571-based cellulose 2 910 (TC-5R: Shin-Etsu Chemical Co., Ltd.) A coated liquid of 900 g of purified water was applied to a plain layer by a coating machine (Dria coater DRC-650 'Powrex) to produce a 275 mg anti-g-ingot per 1 sharp. <Example 1 &gt; 5 500 g of the protective ingot obtained in Production Example 1 using 1180 g of white granulated sugar, 400 g of talc, 400 g of precipitated calcium carbonate, and 66.7 g of ethyl acrylate-methyl methacrylate copolymer 30% dispersion (Eutragit NE3 0D: Suspension coatings made of refined water from the Kawaguchi Chamber of Commerce and 200 g of purified water were dried by a coating machine (Dria coater DRC-650, Powrex) spray-coating solution to obtain 3 75 mg of sugar-coated tablets per ingot. The time taken for the covering operation was 2 hours. &lt;Example 2 &gt; Manufacturing Example 1 at 5 500 g For the protective ingot, use 1160 g of white granulated sugar, 400 g of talc, 400 g of precipitated calcium carbonate, 133.3 § ethyl acrylate·methyl methacrylate copolymer 30% dispersion (Eudragit NE30D: Sakaguchi Chamber of Commerce) and 2 The suspension coating liquid of 0 0 0 g of purified water was dried by a coating machine (Dria coater DRC - 65 0, Powrex) spray coating liquid to obtain a 375 mg sugar-coated tablet per one spindle. In addition, the time required for the covering operation is 2 hours. &lt;Example 3 &gt; -22- 200812571 In 5 500 g of the protective ingot obtained in Production Example 1, 1120 g of white granulated sugar, 400 g of talc, 400 g of precipitated calcium carbonate, and 266.7 g of ethyl acrylate·methacrylic acid were used. The suspension coating solution of the methyl ester copolymer 30% dispersion (Eudragit NE30D: Sakaguchi Chamber of Commerce) and 2000 g of purified water was dried by a coating machine (Dria coater DRC-650, Powrex) spray coating to obtain 1 tablet per spindle. It is a 3 75 mg sugar-coated tablet. In addition, the time required for the covering operation is 2 hours. &lt;Comparative Example 1 &gt; In 5 500 g of the protective ingot obtained in Production Example 1, 1160 g of white granulated sugar, 400 g of talc, 400 g of precipitated calcium carbonate, and 40 g of hydroxypropylmethylcellulose 2910 (TC-5R) were used. : Susukino Chemical Industry Co., Ltd. and 2000 g of purified water to obtain a suspension coating liquid, which was dried by a coating machine (Dria coater DRC - 65 0, Powrex) spray coating liquid to obtain a sugar-coated tablet of 3 75 mg per one. In addition, the time required for the covering operation is 2 hours. &lt;Comparative Example 2 &gt; In 5 500 g of the protective ingot obtained in Production Example 1, 1 924 g of white granulated sugar, 542 g of talc, 81 8 g of precipitated calcium carbonate, 64 g of gum arabic, 3 g of gelatin, 22 g were used. Polyethylene oxide (105) polypropylene oxide (5) ethylene glycol (PEP-101: Freund industry) and 1200g of refined water to form a suspension coating liquid to the coating machine (Dria coater DRC-650, Powrex The traditional sugar coating method of spraying, cooking, and drying the sugar coating liquid was carried out to obtain a sugar-coated tablet of 44 5 mg per one tablet. In addition, the time taken for the work to be covered by -23 - 200812571 is 6.5 hours. &lt;Production Example 2 &gt; Force U into 500 00 of garlic processed product (Oxoamidine, manufactured by Rigaku Chemical Co., Ltd.), 2500 g of lactose, 150 g of hydroxypropylcellulose (HPC-L: Japan Soda), 1200 g Corn starch, l〇〇〇g of crystalline cellulose (Ceolus PH-101: Asahi Kasei) was placed in a high-speed stirring granulator (乂〇 _ 25 : Powrex ), and refined water was added to prepare granules. After drying with a fluidized bed dryer (FLO-5B: Freund Industries), the dried product was granulated by a granulator (Power mill, Showa Chemical Machinery). 50 g of magnesium stearate was mixed with 53 50 g of the obtained whole granules. This was produced by a roller type ingot machine (HP-AP18-SS: 畑铁工所), and a 270 mg of ingot per one spindle was produced. In 5400 g of the obtained ingot, a coating liquid made of 100 g of hydroxypropylmethylcellulose 2910 (TC-5R: Shin-Etsu Chemical Industry) and 90 g of purified water was used as a coating machine (Dria coater). DRC—650, Powrex) is applied with a waterproof layer to the ingot to make a protective ingot of 2 75 mg per ingot. &lt;Example 4 &gt; In 5 5 00 g of the protective ingot obtained in Production Example 2, 1180 g of white granulated sugar, 400 g of talc, 40 g of precipitated calcium carbonate, and 66.7 g of ethyl acrylate·methyl methacrylate were used. The suspension of the copolymer 30% dispersion (Eudragit NE30D: 樋口商会) and 2000g of purified water was suspended -24-200812571 floating sugar coating liquid, dried with a coating machine (Dria coater DRC-650, Powrex) spray coating liquid to obtain each One ingot is 375 mg of sugar-coated sharp. In addition, the time required for the covering operation is 2 hours. &lt;Example 5&gt; In 5 500 g of the protective ingot obtained in Production Example 2, 1160 g of white granulated sugar, 400 g of talc, 400 g of precipitated calcium carbonate, and 133.3 g of ethyl acrylate·methyl methacrylate copolymer were used. A suspension of 30% dispersion (Eudragit NE3 0D: Sakaguchi Chamber of Commerce) and 200 00 g of purified water was dried by a coating machine (Dria coater DRC-650, Powrex) spray coating to obtain 3 per ingot. 75 mg of sugar-coated tablets. In addition, the time required for the covering operation is 2 hours. &lt;Example 6 &gt; In 5 500 g of the protective ingot obtained in Production Example 2, 1120 g of white granulated sugar, 400 g of talc, 400 g of precipitated calcium carbonate, and 266.7 g of ethyl acrylate·methyl methacrylate were used. The suspension of the 30% dispersion (Eudragit NE30D: Sakaguchi Chamber of Commerce) and 2000 g of purified water was dried by a coating machine (Dria coater DRC-650, Powrex) spray coating to obtain 1 per 1 The ingot is a 375 mg sugar-coated tablet. In addition, the time required for the covering operation is 2 hours. &lt;Comparative Example 3> In 5 500 g of the protective ingot obtained in Production Example 2, 1 160 g of 25-200812571 white granulated sugar, 400 g of talc, and sedative hydroxypropyl methylcellulose 2910 (TC- 5R · _ Shin-Etsu Chemical Industry Co., Ltd.) and 2000g of purified water-made suspension coating liquid's coating drying machine (Dria coater DRC 650, P owrex) spray coating liquid under the order of drying 'to get 3 sharp per 1 3 5 Mg sugar ingots. In addition, the time required for the covering operation is 2 hours. &lt;Comparative Example 4 &gt; φ In 5 500 g of the protective ingot obtained in Production Example 2, using 1,924 g of white granulated sugar, 542 g of talc, 818 g of precipitated calcium carbonate, 64 g of gum arabic, 30 g of gelatin, and 22 g of poly A suspension coating of ethylene oxide (105) polypropylene oxide (5) ethylene glycol (PEP-1 0 1 : Freund Industries) and 1 200 g of purified water to a coating machine (Dria coater DRC - 65 0 , P owrex ), a traditional sugar coating method of spraying, cooking and drying the sugar coating liquid, respectively, to obtain a sugar-coated tablet of 445111 § per ingot. In addition, the time taken for the covered work was 6.5 hours. &lt;Production Example 3&gt; The addition of 10 g of methionine acid (methylthioglycolic acid, Yonezawamycin), 600 g of lactose, and 300 g of polyvinylpyrrolidone (CoridonSO: BASF Japan), 1550 g of corn starch, 500 g of CarmeUose calcium (ECG-5 05: Wude Pharmaceuticals) were placed in a high-speed stirring granulator (VG-25: Powrex), and ethanol was added to prepare granules. After drying in a fluidized bed dryer (FLO-5B··Freund Industries), the dried product was granulated by a granulator (Power mill, Showa Chemical Machinery). -26- 200812571 Mix 50g of magnesium stearate with 390mg of whole granules, and use a roller type ingot machine (HP-AP18-SS: 畑铁工所) to make lOOmg per 1 spindle. Prime ingots. In 4000 g of the obtained ingot, 400 g of hardened oil, 100 g of glyceryl monostearate (Nikkol MGS-B: Nikko Chemical) and 100 g of polyethylene glycol monostearate (40EO) (NikkolMYS-40) were used. : Daylight Chemical) In a 600 mL ethanol solution and 200 g of talc, a water-repellent layer was applied to a sharp coating machine (Dria coater DRC-650, Powrex) to produce a protective ingot of 120 mg per ingot. &lt;Example 7&gt; In 4800 g of the protective ingot obtained in Production Example 3, a copolymer of 1180 g of white granulated sugar, 400 g of bone, 400 g of precipitated calcium carbonate, and 66.7 g of ethyl acrylate·methyl methacrylate was used. The suspension of the 30% dispersion (Eudragit NE30D: 樋口商会) and 2000 g of purified water was dried by a coating machine (Dria coater DRC-650, Powrex) spray coating to obtain each mirror. It is a 170 mg sugar-coated tablet. In addition, the time required for the covering operation is 1 hour. &lt;Example 8&gt; In 4 800 g of the protective ingot obtained in Production Example 3, 1160 g of white granulated sugar, 400 g of talc, 400 g of precipitated calcium carbonate, and 133.3 g of ethyl acrylate·methyl methacrylate copolymer were used. 30% dispersion (Eudragit NE30D: 樋口商会) and 2000g of refined water made of suspension -27- 200812571 floating sugar coating liquid, dried with a coating machine (Dria coater DRC - 650, Powrex) spray coating liquid to obtain 1 ingot It is a 70 mg sugar-coated tablet. In addition, the time required for the covering operation is 1 hour. &lt;Example 9&gt; The protective ingot obtained in Production Example 3 of 4 800 g was copolymerized with 1 120 g of white granulated sugar, 400 g of talc, 400 g of precipitated calcium carbonate, and 266.7 g of ethyl acrylate·methyl methacrylate. The suspension of the 30% dispersion (Eudragit NE30D: Sakaguchi Chamber of Commerce) and 2000 g of purified water was dried by a coating machine (Driacoater DRC - 65 0 'Powrex) spray coating to obtain 170 mg per ingot. Sugar coated ingots. In addition, the time required for the covering operation is 1 hour. &lt;Comparative Example 5 &gt; In 4 800 g of the protective ingot obtained in Production Example 3, 1160 g of white granulated sugar, 400 g of talc, 400 g of precipitated calcium carbonate, and 40 g of hydroxypropylmethylcellulose 2910 (TC-5R) were used. : Shin-Etsu Chemical Industry Co., Ltd. and 2000g of purified water to make the suspension coating liquid, which is dried by a coating machine (〇1^(:〇3161〇11€: — 65 0, P 〇wre X ) The amount of time required for the coating operation was 1 hour. The comparative example 6&gt; The protective ingot obtained in the production example 3 of 48 00 g was made of 6 〇 Og of white granulated sugar and 1100 g of talc. 1100g of precipitated calcium carbonate, 280g of A-28-200812571 Labo gum, 60g of gelatin and 600g of refined water to form a suspension coating liquid 'with coating machine (Dria coater DRC-650, Powrex)' A conventional sugar coating method of spraying, cooking, and drying was carried out to obtain a sugar-coated tablet of 200 mg per ingot. The time required for the coating operation was 3.5 hours. &lt;Production Example 4 &gt; 3300 g of sodium valproate and 165 g of light were added. The phthalic anhydride and 303.6 g of ethyl cellulose were stirred at high speed. A granulator (VG-25: Powrex) was added to ethanol to prepare granules, which was dried in a fluidized bed dryer (FL〇_5B: Freund Industries) and then granulated (Power mill, Showa Chemical Machinery). The dried product is granulated. The whole granule obtained by mixing 24 g of calcium stearate with 342 6 g is prepared by using a roller type ingot machine (HP-AP1 8-SS: 畑铁工所). 23 0 mg of bismuth ingot. In 3,220 g of the obtained ingot, dissolved and dispersed 6 〇g of ethyl cellulose, 30 g of methacrylic acid copolymer L (Eudragit L100: 樋口商会), 22.5 g of citric acid triethyl Ester and 22.5g of light oleic anhydride in 1365g of ethanol solution, using a coating machine (Dria coaterDRC - 650' Powrex) to release the control layer in the ingot, then use to dissolve, disperse 60g of ethyl cellulose and 3 〇g of light phthalic anhydride in 1410 g of ethanol solution, and a release control layer (Dria coater DRC-650, Powrex) was applied to release a control layer to produce a release control ingot of 245 mg per ingot. -29 - 200812571 &lt;Example 1&gt; The release control ingot obtained in Production Example 4 of 6 86 g, using white sugar, 3 g of slippery Stone, 51g of precipitated calcium carbonate, 9.9g of ethyl acrylate·methyl methacrylate copolymer 3〇% dispersed EudragitNE30D: 樋口商会) and 135.6g of refined water to make a floating sugar coating liquid, to cover machine (Hicoater HCT- 30N, Freund) was dried under a spray coating to obtain a sugar-coated tablet of 295 mg per 1 tablet (the mass of the coating layer was 5 Omg). In addition, the overlap between the jobs was 40 minutes. &lt;Example 1 1&gt; In 68 6 g of the production control ingot obtained in Production Example 4, white sugar, 6 g of talc, 102 g of precipitated calcium carbonate, and 20.1 g of ethyl acetate·methyl methacrylate were used. The copolymer was 30% dispersed with Eudragit NE30D: 樋口商会) and 270.9 g of purified water to obtain a floating sugar coating solution, which was dried by a coating machine (Hicoater HCT-30N, Freund) spray coating to obtain 3 45 mg per 1 tablet (the clothes thereof) The layer has a mass of l〇〇mg) of a sustained-release sugar-coated tablet. In addition, the time taken for the cover is 75 minutes. &lt;Comparative Example 7 &gt; The release control ingot obtained in Production Example 4 of 68 6g was made up to 2 8 8.6 g of white granulated sugar, 8 1 .3 g of talc, and 1 2 2.7 g of precipitated carbonic acid 9 · 6 g Acacia gum, 4 · 5 g of gelatin, 3.3 g of polyethylene oxide 93 g of enoic acid t (the suspension of sugar in the industry costs 186 g of propylene liquid (the suspension of sugar in the industry by calcium, -30 - ( 105 200812571 ) A suspension sugar coating liquid made of polypropylene oxide (5) ethylene glycol and 180 g of purified water, and a traditional sugar coating of the sugar coating liquid sprayed, cooked and dried by a small sugar-coated machine (made by Kikusui Seisakusho Co., Ltd.) The method 'requires a powdered ingot of 41 5 mg per ingot. The time required for the coating operation is 300 minutes. Further, a suspension icing made of 114 g of white granulated sugar, 6 g of titanium oxide and 72 g of purified water is used. A small sugar-coated machine (made by Kikusui Seisakusho Co., Ltd.) was used to spray, retort, and dry the sugar-coating liquid, respectively, to obtain a color coat of 45 5 mg per ingot. 240 minutes. Finally, use 15g of white sugar and 9g of refined The sugar-coated liquid was prepared by a small sugar-coated machine (made by Kikusui Seisakusho Co., Ltd.), which was sprayed, cooked, and dried, respectively, to obtain a coating of 460 mg (one of which has a sugar coating layer of 215 mg). In addition, the time required for the covering operation was 30 minutes, and the total time required for all the covering operations was 570 minutes. From the above results, it was found that the manufacturing method of the present invention using simultaneous spraying and drying of the coating liquid and the conventional coating method In comparison, it is possible to shorten the working time by one third or less. Further, it is also known that the weight of the sugar coating layer in the sugar-coated tablet may be one-half to one-fourth of a degree. <Evaluation of hygroscopicity> Example 1 to 9, the sugar-coated tablets obtained in Comparative Examples 1 to 6 were ingots, and the mass after standing for 1 hour, 2 hours, 3 hours, and 24 hours was measured under the conditions of 25 ° C to 84.3%, and the quality at the beginning was performed. For comparison, the moisture absorption amount was measured to calculate the moisture absorption rate (%). Further, the sugar-coated ingots obtained in Examples 10 to 1 1 and Comparative Examples 7 to 31 200812571 were subjected to the conditions of 40 ° C - 7 5 %. 'Measurement for 3 hours, 1 day, 2 The moisture absorption rate (%) was calculated in the same manner as above for the masses of 3 days, 7 days, 10 days, 14 days, 21 days, 28 days, and 3 days. The results are shown in Figures 1 to 4. (%) = (1 barium ingot mass after each time of storage - 1 bardle tablet mass at the beginning) / 10 spindle masses at the beginning xl 00 According to Figure 1, the sugar coating formulations of Examples 1 to 3 Even after standing for 24 hours under the above conditions, the moisture absorption rate was low, being 1%. When the sugar-coating preparation of Comparative Example 1 was allowed to stand for 3 hours, the moisture absorption rate was 0.2%, and when it was allowed to stand for 24 hours, the moisture absorption rate was increased to nearly 1.2%. Further, when the sugar-coating preparation of Comparative Example 2 was allowed to stand for 24 hours, the moisture absorption rate was increased to about 0.5%. According to Fig. 2, the sugar-coating preparations of Examples 4 to 6 were allowed to stand for 24 hours under the above conditions, and the moisture absorption rate was as low as 0.1%. When the sugar-coating preparation of Comparative Example 3 was allowed to stand for 3 hours, the moisture absorption rate was 0.4%, and when it was allowed to stand for 24 hours, the moisture absorption rate was increased to nearly 2.1%. Further, when the sugar-coating preparation of Comparative Example 4 was allowed to stand for 24 hours, the moisture absorption rate was increased to about 0.5%. According to Fig. 3, the sugar-coated preparations of Examples 7 to 9 and Comparative Example 6 were allowed to stand for 24 hours under the above conditions, and the moisture absorption rate was as low as 0.5% or less. When the sugar-coated preparation of Comparative Example 5 was allowed to stand for 3 hours, the moisture absorption rate increased to nearly 1.3%, and when it was left to stand for 24 hours, it increased to nearly 5.6%. According to Fig. 4, in the sugar-coated preparations of Examples 10 and 11, even if the quality of the sugar-coated layer was about 1/1 and 1/1 of that of Comparative Example 7, the moisture absorption rate after 30 days was extremely low. , respectively, 2.0% and 1.0%. In contrast, in the sugar-coated preparation of Comparative Example 7, the rate of moisture absorption -32-200812571 was nearly 4.0% at the stage after 7 days, and further, after 10 days, the tablet was broken. It is speculated that the tablet breakage is due to the hygroscopicity of sodium valproate. From the above, it can be seen that when the sugar coating liquid of the present invention is used, even when the sugar coating preparation is produced by a coating method of drying under a sugar coating liquid, an excellent sugar-soluble preparation having low hygroscopicity can be obtained as compared with the conventional sugar coating preparation. &lt;Evaluation of physical properties&gt; The hardness and degree of collapse of the sugar-coated tablets obtained in Examples 1 to 9 and Comparative Examples 1 to 6 were measured. In the hardness, 20 spindles were used, and the hardness of the tablet was measured for each tablet in a tablet hardness tester (ΡΤΒ-311Ε manufactured by PHARMATEST Co., Ltd.) to calculate the average enthalpy. The degree of ablation was measured by a subsidy plate according to the collapse test method described in the 15th revision of the Japan Pharmacopoeia (Toyama Industrial Co., Ltd. collapse tester). The test was carried out on 6 spindles to calculate the average enthalpy. The results are shown in Tables 1 to 3. [Table 1] Example 1 Example 2 Example 3 Comparative Example 1 Comparative Example 2 Hardness (N) 120.2 148.6 116.1 71.6 142.7 Degree of collapse (parts) 22.4 21.0 20.6 29.9 30.9 The sugar coating preparations of Examples 1 to 3 were sufficient. The hardness is also excellent in collapse. On the other hand, the sugar coating preparation of Comparative Example i was insufficient in hardness and collapse. The sugar-coated preparation of Comparative Example 2 had high hardness but was insufficient in collapse. -33- 200812571 [Table 2] Table 2 Example 4 Example 5 Example 6 Comparative Example 3 Comparative Example 4 Hardness (N) 118.5 120.3 125.8 91.8 138.5 Degree of collapse (parts) 20.5 22.3 21.9 28.3 32.1 Examples 4 to 6 The sugar-coated preparation had sufficient hardness and was excellent in collapse property. On the other hand, the sugar:coating preparation of Comparative Example 3 was insufficient in hardness and collapse property. Comparing the sugar of Example 4; although the night preparation has high hardness, it is insufficient in collapse. [Table 3] Table 3 Example 7 Example 8 Example 9 Comparative Example 5 Comparative Example 6 Hardness (N) 72.8 76.5 81.8 59.8 92.9 Degree of collapse (parts) 12.1 11.5 12.2 11.9 18.5 The sugar-coated preparations of Examples 7 to 9 have It has sufficient hardness and is excellent in collapse property. On the other hand, the sugar coating preparations of Comparative Examples 5 and 6 were insufficient in hardness and collapse property. From the above, it is understood that the sugar-coated preparation of the present invention has sufficient hardness and is excellent in collapse property. &lt;Evaluation of Odor&gt; The odor of the sugar-coated tablets obtained in Examples 4 to 9 and Comparative Examples 3 to 6 was evaluated. After sealing the obtained preparation in a transparent glass bottle, at 60 ° C, the odor generated when stored for 3 days, 1 week or 2 weeks, 〇: completely -34- 200812571 did not feel the unpleasant smell from the drug Taste, 1: almost no unpleasant odor from the drug, 2: feeling: unpleasant odor from the drug, 3: strong feeling: a 4-stage evaluation of the unpleasant odor from the drug sputum. The evaluation is conducted by 5 people: line, and the average value of f is calculated. The results are shown in Tables 4 to 5. [Table 4] Table 4 Example 4 Example 5 Example 6 Comparative Example 3 Comparative Example 4 Immediately after manufacture 0 0 0 0 0 After 3 days 0 0 0 1.2 0 After 1 week 0 0 0 2.6 0 After 2 weeks 0 0 0 3.0 0 The sugar-coated preparations of Examples 4 to 6 and Comparative Example 4 did not feel the unpleasant odor from Oxoami dine at all during the storage period of 2 weeks. In another aspect, the sugar-coated preparation of Comparative Example 3 strongly felt the unpleasant odor from Oxoam i dine. In particular, it is understood that the unpleasant odor becomes stronger as the storage is longer. [Table 5] Table 5 __一^-- Example 7 Example 8 Example 9 Comparative Example 5 Comparative Example 6 - Immediately after manufacture 0 0 0 0 0 After 3 days 0 0 0 2.2 0 After 1 week 0.4 0.4 0.6 3.0 1.2 After 2 weeks 1.2 1.4 1.4 3.0 1.4 The sugar-coated preparations of Examples 7 to 9 and Comparative Example 6 did not feel the unpleasant odor from MMSC at all during the storage period of 2 weeks. On the other hand, in the case of -35-200812571, the sugar-coated preparation of Comparative Example 5 felt an unpleasant odor from MMSC after 3 days, and an unpleasant odor was strongly felt after 1 week. From the above, it is understood that the sugar-coated preparation of the present invention is superior in deodorizing property as compared with the conventional sugar-coated preparation. &lt;Evaluation of moisture 刚 immediately after manufacture&gt; Examples 7 to 9 after pulverization: The sugar-coated tablets of Comparative Examples 5 to 6 were weighed and taken up to about 5 g, and calcium hydroxide was used as a reaction reagent, and it was measured by a barometric moisture meter. In 〇 minutes, the moisture 値 (%) was calculated. The results are shown in Table 6. [Table 6] Table 6____Example 7 Example 8 Example 9 Comparative Example 5 Comparative Example β Moisture 値 (%) 1.65_L55_L62_L56_2.48 The sugar-coated preparations of Examples 7 to 9 and Comparative Example 5 The moisture 値 (%) was lower than that of the sugar coating preparation of Comparative Example 6. Therefore, it has been found that when the continuous coating method is used, the moisture enthalpy in the tablet can be reduced as compared with the conventional coating method. &lt;Dissolution test&gt; The dissolution test of the sugar-coated tablet of Example 1 was carried out. The test was carried out according to the second method (refrigeration) method of the Pharmacy Dissolution Test Method of the Pharmacy, and the second liquid of the 500% test of the general test method collapse test was used as the test liquid at 10 rpm. The sodium valproate content in the sample solution was quantified by HPLC, and the dissolution rate (%) of sodium valproate was calculated. The result is shown in Figure 5 of _ 36 - 200812571. As is clear from Fig. 5, the sugar-coated preparation of the present invention is also excellent in sustained release property. According to the above, the sugar coating liquid of the present invention is effectively used for the formulation of a sugar coating which requires a sustained release drug. As described above, the sugar-coated preparation of the present invention is produced by a continuous coating method, and has a sufficient hardness as compared with a conventional sugar-coated preparation, and is excellent in low hygroscopicity and odor-reducing property, and is coated by a sugar coating method. The conventional sugar-coated preparation produced can be produced by a short-time coating operation, and has a low moisture content after production and an excellent disintegration property. In other words, according to the production method of the present invention, even if the sugar coating layer is thin, it has sufficient hardness, and it is possible to produce low moisture content, low moisture absorption property, collapse property, and odor resistance immediately after production in a short time and in a simple manner. Sugar coating preparation. [Industrial Applicability] Using the sugar coating liquid of the present invention, a sugar coating preparation can be produced by simultaneously performing a spraying step of a sugar coating liquid and a continuous coating method of a drying step. In other words, it is possible to produce a sugar-coated preparation having low oxygen permeability, low moisture absorption, odor resistance, and collapse property in a short period of time without complicated steps. Further, since the production method of the present invention can form a thin sugar-coated layer, it greatly contributes to the reduction in the amount of the sugar-coating liquid used and the miniaturization of the preparation. [Simplified description of the drawings] [Fig. 1] shows the change in moisture absorption rate of the elapsed time and the sugar coating preparation. Fig. 2 is a graph showing the change in moisture absorption rate of -37-200812571 of the elapsed time and the sugar-coated preparation containing the garlic processed product. Fig. 3 is a graph showing changes in moisture absorption rate of elapsed time and a sugar-coated preparation containing MMSC. Fig. 4 is a graph showing changes in the moisture absorption rate of the elapsed time and the sugar-coated preparation containing sodium valproate. Fig. 5 is a graph showing the elapsed time and the change in the dissolution rate of sodium valproate.

-38--38-

Claims (1)

200812571 十、申請專利範園 1. 一種糖衣液,含糖、丙烯酸乙酯·甲基丙燒酸甲 酯共聚物及溶劑之糖衣液,其特徵爲,丙烯酸乙酯·甲基 丙烯酸甲酯共聚物之濃度係相對於總固形物爲0.01〜10 重量%。 2 · —種糖衣製劑,具有含藥物之芯材,以及被覆該 芯材之糖衣層之糖衣製劑,其特徵爲,該糖衣層之至少1 應 層含有0.01〜10重量%之糖及丙烯酸乙酯·甲基丙烯酸甲 酯共聚物。 · 3 .如申請專利範圍第2項之糖衣製劑,其中更具有 釋出控制層。 4.如申請專利範圍第2項或第3項之糖衣製劑,其 中藥物係具有不愉快臭味之藥物、對水份不安定之藥物、 或發生晶鬚之藥物。 5 · —種糖衣製劑之製造方法,其特徵爲,同時進行 _ 如申請專利範圍第1項之糖衣液之噴霧步驟、及乾燥步驟 -39 -200812571 X. Application for Patent Park 1. A sugar coating liquid, a sugar coating solution containing sugar, ethyl acrylate, methyl propyl acetonate copolymer and solvent, characterized by ethyl acrylate·methyl methacrylate copolymer The concentration is 0.01 to 10% by weight based on the total solids. 2 - a sugar-coated preparation having a drug-containing core material and a sugar coating preparation covering the sugar coating layer of the core material, characterized in that at least one layer of the sugar coating layer contains 0.01 to 10% by weight of sugar and ethyl acrylate • Methyl methacrylate copolymer. · 3. A sugar-coated preparation as claimed in claim 2, which further has a release control layer. 4. A sugar-coated preparation according to item 2 or item 3 of the patent application, wherein the medicine is a drug having an unpleasant odor, a drug which is unstable to moisture, or a drug which generates whiskers. 5 - A method for producing a sugar-coated preparation, characterized in that the spraying step of the sugar-coating liquid as in the first application of the patent scope, and the drying step - 39 -
TW096126949A 2006-07-25 2007-07-24 Sugar-coated preparation and process for producing the same TW200812571A (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP2006201731 2006-07-25
JP2006308050 2006-11-14
JP2006338547 2006-12-15
JP2007132001 2007-05-17

Publications (1)

Publication Number Publication Date
TW200812571A true TW200812571A (en) 2008-03-16

Family

ID=38981396

Family Applications (1)

Application Number Title Priority Date Filing Date
TW096126949A TW200812571A (en) 2006-07-25 2007-07-24 Sugar-coated preparation and process for producing the same

Country Status (5)

Country Link
JP (3) JPWO2008013084A1 (en)
KR (1) KR20090037951A (en)
CN (1) CN101495101B (en)
TW (1) TW200812571A (en)
WO (1) WO2008013084A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4803686B2 (en) * 2010-08-31 2011-10-26 協和発酵キリン株式会社 Granules and orally disintegrating tablets containing a bitter-tasting drug
CN104367625A (en) * 2014-11-03 2015-02-25 成都森科制药有限公司 Method for preparing selfheal tablet
FR3067567B1 (en) * 2017-06-19 2019-07-05 Roquette Freres NEW DRAGEIFICATION PROCESS AND DRAGED SOLID FORMS HAVING IRREGULAR SHAPES

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2449384A1 (en) 1974-10-17 1976-04-29 Roehm Gmbh METHOD OF MANUFACTURING MEDICINAL CONES
GB1500300A (en) * 1975-01-06 1978-02-08 Ciba Geigy Ag Pharmaceutical preparation for the treatment of circulatory disorders
JPS5244224A (en) * 1975-10-01 1977-04-07 Yamanouchi Pharmaceut Co Ltd Printing on sugar-coated tablets
CH666405A5 (en) * 1985-06-24 1988-07-29 Ciba Geigy Ag SOLID, DURABLE PHARMACEUTICAL FORMS WITH ELASTIC FILM COVER.
DE19615812A1 (en) * 1996-04-20 1997-10-23 Boehringer Mannheim Gmbh Pharmaceutical preparation containing diphosphonic acids for oral administration
JP2004010611A (en) * 2002-06-06 2004-01-15 Nisshin Yakuhin Kogyo Kk Masking composition
JP2004155656A (en) * 2002-11-01 2004-06-03 Kao Corp Dragees
WO2004108164A1 (en) * 2003-06-04 2004-12-16 Kyowa Hakko Kogyo Co., Ltd. Composition for coating and coated preparation
WO2005039542A1 (en) * 2003-10-27 2005-05-06 Yamanouchi Pharmaceutical Co., Ltd. Drug-containing coated microparticle for orally disintegrating tablet
PE20060245A1 (en) * 2004-06-07 2006-05-03 Wyeth Corp SUGAR COATINGS AND METHODS FOR THE MANUFACTURE OF THE SAME

Also Published As

Publication number Publication date
WO2008013084A1 (en) 2008-01-31
CN101495101B (en) 2012-02-29
CN101495101A (en) 2009-07-29
KR20090037951A (en) 2009-04-16
JP2014221847A (en) 2014-11-27
HK1132664A1 (en) 2010-03-05
JPWO2008013084A1 (en) 2009-12-17
JP2013100365A (en) 2013-05-23

Similar Documents

Publication Publication Date Title
CN101987081B (en) Controlled release preparation
AU2006281415B2 (en) Pancreatin micropellet cores suitable for enteric coating
JP4868695B2 (en) Oral preparation with good disintegration
JP5401327B2 (en) Tablets with improved dissolution
CN1530139A (en) Compositions comprising sucralose
CN101927002B (en) Medicament and coating composition
WO2006123678A1 (en) Stable tablet containing droxidopa
TWI483748B (en) Pharmaceutical composition containing hydromorphone and naloxone
TWI697341B (en) Coated tablets and the production thereof
EP2470165B1 (en) Film coating composition from solid powder compounds
JP5787762B2 (en) Coating film, granule and tablet using the same
TW200812571A (en) Sugar-coated preparation and process for producing the same
JP5454162B2 (en) Film-coated solid preparation containing sublimable component
CN102000344B (en) Medicament coating composition with masked taste
JP4716063B2 (en) Unpleasant taste masking particles and oral preparations containing the same
JP2006188473A (en) Method for producing coated granules
JPH0334928A (en) Oral administration preparation for treating ulcerative colitis and crohn&#39;s disease
JP2022161887A (en) Solid pharmaceutical composition
HK1132664B (en) Sugar-coated preparation and process for producing the same
JP5608626B2 (en) Film coating composition and oral solid preparation
JP2024039317A (en) Composition for film coating, solid preparation, and method for producing solid preparation
JP5248060B2 (en) Sugar-coated preparation containing silicone and method for producing the same
RU2609198C1 (en) Solid drug form of imipramine with immediate release and method of obtaining thereof
KR20240128588A (en) Aqueous composition comprising hydroxypropyl methyl cellulose acetate succinate and method for producing solid preparation
JP2007530585A (en) Stable coating containing sterol